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Chapter 1
Introduction
Glycosylphosphatidylinositol Anchoring: An Essential Post-Translational
Modification Mediated by GPI-T
1.INTRODUCTION
Glycosylphosphatidylinositol

transamidase

(GPI-T)

is

a

multi-subunit,

membrane-bound enzyme localized in the endoplasmic reticulum (ER) (1). In
eukaryotes, this enzyme mediates GPI (glycosylphosphatidylinositol) transamidation,
an essential post-translational protein modification (2-4). GPI-T utilizes a proprotein
substrate with a C-terminal GPI-T signal sequence and a nucleophilic substrate (the
GPI anchor) to mediate the GPI transamidation reaction (Figure 1.1).
During this process, GPI-T first recognizes and cleaves the C-terminal signal
sequence of the proprotein substrate. Next GPI-T mediates the attachment of the
GPI anchor to the new C-terminus of the protein substrate to produce the GPI
anchored protein (GPI-AP) (1). During this process, a new amide linkage is formed
between the protein and the GPI anchor. GPI-APs are then transported from the ER
to extracellular membranes/cell wall via intracellular secretory pathways.

2

Figure 1.1 The GPI transamidation reaction. GPI-T mediates the
attachment of a GPI anchor to a protein based on recognition and cleavage of
the C-terminal GPI-T signal sequence to produce GPI-APs.
Roughly, 0.5% of proteins encoded in eukaryotes (10–20% of all membrane
proteins) are predicted to be GPI anchored (5,6). GPI-APs perform a wide variety of
functions essential for the well-being of eukaryotic organisms (e.g. enzymes,
receptors, etc). In yeast, GPI anchored cell wall proteins are necessary for cell
viability and cellular morphology (4,7). In parasitic protozoa, the high density of GPIanchored glycoproteins acts as a protective coat against host specific immune
responses (8). In addition to GPI-APs contributions towards the well-being of
eukaryotic organisms, GPI-T itself and several GPI-APs are associated with various
disorders and diseases. For instance, overexpression of certain GPI-T subunits
induces tumorigenesis (9-11) and deficiencies in GPI transamidation lead to
paroxysmal nocturnal hemoglobinuria, an acquired hemolytic disease (12,13).

3
GPI transamidation is an essential reaction for eukaryotic organisms (2-4).
However, because of being a structurally complicated, multi-subunit, transmembrane
protein complex, little is known about GPI-T at a molecular level. So far five subunits
have been identified which make the putative GPI-T complex (1). In yeast, these
subunits are Gpi8, Gpi16, Gaa1, Gpi17 and Gab1. The corresponding human
homologues are PIG-K, PIG-T, GPAA1, PIG-S and PIG-U respectively. Gpi8/PIG-K
is the catalytically active subunit; functions for the other subunits are not well
established. Therefore, it is important to conduct further research to obtain a clear
picture of the structure, stoichiometry, and the functions of the GPI-T subunits and
hence the overall GPI-T complex.

1.1 The Substrates for GPI-T
1.1.1 GPI Anchor - the Nucleophilic Substrate for GPI-T
GPI anchors are group of complex glycolipids found in eukaryotic organisms.
These anchors are essential for well being of eukaryotic organisms (2,4,7,13-15). In
eukaryotic cell, one major role of GPI anchors is as a substrate for GPI-T that is
used to produce GPI-APs. These GPI-APs are ultimately tethered to extracellular
membranes as peripheral proteins via their attached GPI anchor. In addition, GPI
anchors are involved in a plethora of other biological roles. Such roles of GPI anchor
include structural and conformational changes of GPI anchored proteins (16,17),
signal transduction (18,19), cellular communication (20), sorting of GPI-APs to
different domains of cell membrane (21,22), etc.

4
1.1.1a The Discovery of GPI anchor
The pathway to the discovery of the GPI anchor was initiated in 1976, when a
new phospholipase was purified from Bacillus cereus by Ikezawa and coworkers
(23). This phospholipase, named phosphatidylinositol phospholipase C (PI-PLC),
converts alkaline phosphatase (APase) from a membrane-anchored form to a
completely soluble protein (24). Following this discovery, several other isoforms of
PI-PLC, all capable of releasing soluble APase from the membrane, were identified
from different bacteria including Staphylococcus aureus, Clostridium novyi and
Bacillus thuringiensis (25-27). In addition to APase, treatment with PI-PLC converted
other membrane-anchored proteins, including 5‟-nucleotidase and erythrocyte
acetylcholinesterase (AChE) into soluble forms (28,29) Interestingly, PI-PLC specific
substrate proteins were not substrates for other phospholipases (30). This
observation indicated that the PI-PLC sensitive proteins were attached to the plasma
membrane via an anchor containing phosphatidylinositol (PI).
The identification of other PI-PLC specific proteins, including variant surface
glycoprotein (VSG) of Trypanosoma brucei (31,32); rat brain and thymocyte Thy-1
(33,34); Torpedo electric ray organ AChE (35); and human erythrocyte AChE (36);
revealed many important aspects of the GPI anchor. For instance, analysis of the
linkage and the membrane anchor of the rat brain and thymocyte Thy-1 revealed
that this protein‟s C-terminal cysteine was connected to an ethanolamine (EtN) via
an amide bond. Further, it also revealed that the membrane anchor of Thy-1
contained a glycan core and a phospholipid tail. This glycan core consists of
glucosamine, galactosamine, mannose and

myo-inositol residues and the
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phospholipid tail consists of phosphate, glycerol and a stearic acid. Based on these
findings and in combination with exoglycosidase digestions and structure analysis
techniques such as nuclear magnetic spectroscopy (NMR), the first complete
structure of the membrane anchor (GPI) of Trypanosoma brucei VSG (37) and the
rat brain and thymocyte Thy-1(38) was elucidated in 1988 (Figure 1.2).

Figure 1.2 The structure of the rat brain and thymocyte Thy-1 GPI anchor.
Phosphatidylinositol (black), glucosamine (orange), mannose 1, 2 and 3 (blue)
and ethanolamine phosphate (red) represents the core GPI anchor of eukaryotic
organisms. The structure of the lipid portion of the phosphatidylinositol can varied
according to species and tissue of origin. Molecules highlighted in magenta are
only part of Thy-1 GPI anchor and do not represents the eukaryotic GPI anchor
core. The circled free amine group represents the nucleophile donor.
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1.1.1b The Structural Diversity of GPI anchor
To date, complete structures of a diverse set of GPI anchors have been
identified (Figure 1.3) (39-44). All GPI anchors characterized so far have a common
core structure: H2N-(CH2)2-PO4-6Man-(α1-2)-Man-(α1-6)-Man-(α1-4)-GlcNH2-(α1-6)myo-inositol-1-PO4-lipid (Figure 1.2) (45,46). Further modifications to this common
core structure based on its protein, tissue, or species-specificity result in the
structural diversity of GPI anchors (30). Modifications occur frequently on the
tetrasaccharide glycan core and the phospholipid tail of the GPI anchor, during its
biosynthesis or after attachment to GPI anchoring proteins (47). Attachment of
additional carbohydrate side chains such as mannose, galactose and sialic acid, and
extra phosphoethanolamine (EtNP) groups, are also known (46,48-50). For most
GPI anchors, the phospholipid tail contains a diacylglycerol (31,51). However, in
certain GPI anchors the phospholipid tail contains an alkylacylglycerol (52-55) or a
ceramide moiety (39,48,56,57). The length of the carbon chain and the level of
saturation of these lipids vary based on the protein attached, and with tissue and
species specificity (48). Lipidation (acylation) at the 2‟-hydroxyl position of the myoinositol ring is also known (58). This modification is significant, as it eliminates PIPLC specificity.

7

Figure 1.3 Structural diversity of GPI anchors. GPI-Aps of (A) T.brucei
variant
surface
glycoprotein
(VSG)
(B)
human
erythrocyte
acetylcholinesterase (AChE) (C) rat brain Thy-1 cell surface antigen (Thy-1)
(D) Leishmania major gp63 surface protein (gp63) and (E) S.cerevisiae
glycophospholipid-anchored surface protein (Gas1).
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1.1.1c The Biosynthesis of GPI anchor
The assembly of the GPI anchor (Figure 1.4) is initiated at the cytoplasmic
leaflet of the ER membrane.

Figure 1.4 The GPI anchor biosynthetic pathway. This figure illustrates the
general steps involved in GPI anchor biosynthesis in yeast and mammals.
See text for further details.

First, an N-acetylglucosamine (GlcNAc) is added to phosphatidylinositol (PI).
The PI is anchored to the cytoplasmic surface of the ER membrane via a
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diacylglycerol (59). This reaction is the first committed step in GPI anchor
biosynthesis and generates N-acetylglucosaminylphosphatidylinositol (GlcNAc-PI).
GlcNAc-PI production is mediated by GPI-N-acetylglucosaminyltransferase (GPIGnT) (60). The GlcNAc-PI is next deacetylated by GlcNAc-PI de-N-acetylase to
generate glucosaminylphosphatidylinositol (GlcN-PI) (61,62). In mammals and yeast,
a flipping reaction, mediate by flippase, inverts GlcN-PI so that the GlcN is on the
luminal side of the ER membrane (63). The identity of this flippase has remained
elusive. Interestingly, in T. brucei, flipping of GlcN-PI to ER lumen is not required.
Instead, the last step in trypanosomal GPI anchor biosynthesis requires the
corresponding intermediate to flip to the ER lumen to in order to undergo GPI
transamidation (64,65).
Next, the 2‟-hydroxyl position of the inositol in GlcN-PI undergoes an acylation
reaction (palmitoylation is most common) to produce GlcN-(acyl)-PI (66-68). This
reaction is mediated by an inositol acyltransferase and produces PI-PLC-resistant
GPI anchors. Acylation enhances the efficiency of consequent mannosylation
reactions (66,69). The isoprenoid Dolicholphosphomanose (Dol-P-Man) provides the
mannose residues required to construct the GPI glycan core (70). A series of distinct
mannosyltransferases (GPI-MT I-IV) (71-79) sequentially add each mannose to
GlcN-(acyl)-PI. The first mannose (Man1) is attached to GlcN-(acyl) PI via α1-4
linkage to produce Man1-GlcN-(acyl)-PI; this reaction is mediated by α1-4
mannosyltransferase (GPI-MT I) (71). In yeast and mammalian cells, the catalytically
active site of GPI-MT I complex is on the luminal side of the ER. This enzyme
indicates the importance of an early flipping of GlcN-(acyl) PI complex from the
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cytosolic surface of the ER membrane to that of the lumenal surface (43). The
second mannose (Man2) is attached to Man1-GlcN-(acyl)-PI via α1-6 linkage to
produce

Man2-Man1-GlcN-(acyl)-PI.

This

reaction

is

mediated

by

α1-6

mannosyltransferase (GPI-MT II) (74,75). The third mannose (Man3) addition is
mediated by α1-2 mannosyltransferase (GPI-MT III) that produces Man3-Man2-Man1GlcN-(acyl)-PI (76,77).
Mutagenic studies revealed the existence of a Man2-(EtNP)-Man1-GlcN(acyl)-PI, in which, an ethanolamine phosphate (EtNP) is attached to the Man 1 of the
GPI glycan core. This modification, mediated by GPI-ethanolamine phosphate
transferase (GPI-ET I), occurs prior to the attachment of the Man3 to GPI glycan core
(50,80,81). This Man1 modification is essential for GPI transamidation in yeast (81)
but not in mammals or T. brucei (80,82). A second EtNP is attached to the Man3 of
the glycan core to produce (EtNP)-Man3-Man2-(EtNP)-Man1-GlcN-(acyl)-PI (83,84).
The free amine group (Figure 1.1, circled amine group) of this final EtNP attached to
Man3 is the nucleophile donor used in the GPI transamidation reaction. In yeast and
certain mammalian cell lines, there is a stringent requirement for a fourth mannose
group before addition of the EtNP to the Man 3 (78,85). The enzyme α1-2
mannosyltransferase (GPI-MT IV) (78,79) mediates this reaction to produce Man4Man3-Man2-(EtNP)-Man1-GlcN-(acyl)-PI. This reaction is followed by the addition of
EtNP moiety to the Man3 of the GPI anchor to produce the Man4-(EtNP)-Man3-Man2(EtNP)-Man1-GlcN-(acyl)-PI. In addition to the EtNP groups attached to the Man1
and Man3 of the GPI anchor, a third EtNP is attached to the Man 2 (86,87). In yeast,
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this modification is important for ER to Golgi transport of GPI-APs, ceramide
remodeling of the GPI phospholipid tail and to maintain cell wall integrity (88).
The two structures, (EtNP)-Man3-Man2-(EtNP)-Man1-GlcN-(acyl)-PI and
Man4-(EtNP)-Man3-Man2-(EtNP)-Man1-GlcN-(acyl)-PI represent the minimalist GPI
anchors of eukaryotic organisms. These structures can act as nucleophilic
substrates for GPI transamidase to produce GPI-APs or can exist as free GPIs on
extracellular membranes (89). Further modifications can be introduced to the GPI
anchor, even after its attachment to proteins. Such modifications, including inositol
deacylation and lipid remodeling, will be discussed later in this chapter.

1.1.1d GPI Anchor Mimics to Substitute the GPI Anchor
GPI anchors are ubiquitous to eukaryotic systems. However, the extraction of
GPI anchors from biological systems with high yield and purity is very challenging.
As an alternative, currently there exist several synthetic pathways to construct GPI
anchors and various derivatives in vitro (90-101).These synthetic strategies provide
an invaluable approach to successfully construct full-length GPI anchors and
anchored peptides. However, large-scale production of GPI anchored products is
challenging and still an ongoing problem. Further, the amphipathic nature of both
natural and synthetic full-length GPI anchors restricts their use in soluble in vitro
experiments.
Due to the challenges associated with the use of full-length GPI anchors,
GPI-T researches seek GPI anchor mimics to substitute the GPI anchor. Inspired
from the work of S. S. Tate and A. Meister (102), in 1995, Udenfriend and co-
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workers

employed

small

nitrogen

nucleophiles,

such

as

hydrazine

and

hydroxylamine, to mimic the GPI anchor (103,104). In in vitro assay systems, high
concentrations of these mimics were successfully used as substrates in the GPI
transamidation reaction. These small compounds were attached to the correct amino
acid in the protein substrate in a manner that was analogous to that of the GPI
anchor (105).This discovery opened up a new avenue to characterize various
aspects of GPI transamidation using more convenient soluble assay systems. The
awareness that small molecules can substitute for the GPI anchor opened doors for
the synthesis of simplified, but more realistic, soluble GPI anchor mimics to replace
GPI anchors in in vitro studies (97,106).

1.1.2 The Protein Substrate for GPI-T
The discovery of proteins post-translationaly modified with C-terminal GPI
anchors was initiated in the late 1970s, when two research groups independently
demonstrated the release of membrane bound alkaline phosphatase by bacterial PIPLC treatment (23,24). As detailed in section 1.1.1a, this experiment ultimately led to
the identification of GPI anchor and the discovery of a diverse set of GPI-APs.
Hundreds of proteins have been identified or predicted to be GPI anchored to date
(5,6). These proteins are first synthesized in the cytosol, as a preproprotein with a
canonical N-terminal ER localizing signal sequence and a C-terminal GPI-T signal
sequence

(107).

The

N-terminal

signal

sequence

directs

co-translational

translocation of the precursor preproprotein to the ER lumen (108,109). This
localizing signal sequence is then cleaved by signal peptidases and the
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preproprotein is converted to a proprotein. The cleaved N-terminal sequence is not a
prerequisite for consequent GPI anchor attachment (110). The C-terminal GPI-T
signal sequence is important to target the proprotein substrate to the GPI-T and for
GPI-T to recognize it‟s substrate proteins (107,109). This signal sequence is not a
consensus sequence. However, it can be divided into three key identity regions
(Figure 1.5). These regions include the GPI-T cleavage and anchor attachment
region (the so-called ω region, 3 amino acids), a hydrophilic spacer region (10-12
amino acids) and a terminal hydrophobic region (12-20 amino acids).

Figure 1.5 The protein substrate for GPI-T. The C-terminal GPI signal sequence
begins at the ω site and is followed by stretches of hydrophilic and hydrophobic
amino acids.

1.1.2a The ω Region
The ω region begins with a ω amino acid followed c-terminally by the ω+1
and ω+2 residues. GPI-T cleaves the amide bond between the ω and ω+1 positions,
replacing the C-terminal peptide (from the ω+1 position to the C-terminus) with the
GPI anchor. Site directed mutagenesis experiments to characterize the ω site were
performed by various research groups (111-118). Using nascent human placental
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alkaline phosphatase (PLAP) and a minimalistic version of PLAP called miniPLAP,
Udenfriend and co-workers evaluated the amino acid requirements at the ω site. The
native ω site in wild-type PLAP is Asp484 (Asp179 in miniPLAP). When this position
was mutated to glycine, alanine, cysteine, serine, or asparagine, the mutants were
expressed well and the resultant protein was GPI anchored. However, mutation to
glutamic acid, glutamine, proline, tryptophan, leucine, valine, phenylalanine,
threonine, methionine, and tyrosine produced proproteins that were not converted to
GPI-APs (111-114).These results suggested that the ω site residue must be
relatively small.
A similar set of experiments were carried out by Caras and co-workers
(115,116). They developed the fusion protein hGH-DAF, by appending the Cterminal GPI signal sequence of human decay accelerating factor (DAF) onto the C
terminus of human growth hormone (hGH), a secretory protein. Site directed
mutagenesis of the Ser319 ω site of DAF to alanine, aspartate, asparagine and
glycine allowed for efficient GPI anchoring compared to mutations to either valine or
glutamate. However, in contrast to the results of Udenfriend and co-workers,
mutation to cysteine completely abolished GPI anchoring of hGH-DAF. In summary,
these and other experiments led to the conclusion that the ω site amino acid should
be a small and relatively hydrophobic amino acid for recognition by GPI-T.
A similar approach was used to characterize the amino acid specificity at the
ω+1 and ω+2 residues (117-120). In 1992, the amino acid specificity at ω+1 site
was investigated using an in vitro cell free system built from rabbit reticulocyte
lysates and rough microsomes (RM), using preprominiPLAP as the protein substrate
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(120).This preprominiPLAP construct was designed by removing a significant
amount (2/3) of internal sequence of humanPLAP. However, the N and C-terminal
regions, which represent the pre and pro regions of hPLAP was retained as it is on
preprominiPLAP. In the natural construct of preprominiPLAP, Asp179, Ala180 and
Ala181 represent the ω, ω+1 and ω+2 sites, respectively. Mutations at Ala180 to
Asp, Ser, Cys, Met, Thr, Glu, Arg, and Trp were well tolerated; however, mutation to
proline eliminated GPI-T recognition and processing. Mutational studies at ω+1 and
ω+2 were also carried out in vivo using wild type PLAP cDNA transfected to COS
cells (119). In conclusion, all of these studies revealed that the ω + 1 site tolerates
all amino acids except proline, with a preference for small amino acids (117,118).
The amino acid specificity at ω+2 site is more stringent and restricted to very small
amino acids including Ala, Gly, Ser and Cys (117-120). In fact, alanine and glycine
are optimal at ω+2 site although trace activity was observed with cysteine and serine
(120).

1.1.2b The Spacer Region
The ω region is followed by a stretch of hydrophilic amino acids also known
as the spacer region. Mutational analysis of the GPI-T signal sequences of human
DAF (116,121), bovine liver 5'-nucleotidase (122), S. cerevisiae Gas1(57),(118), and
the unnatural signal sequence Ser3-Thr8-Leu14 appended to cluster of differentiation
46 protein (CD46) (117) revealed much about this spacer region. According to those
facts, the spacer region does not contain any consensus sequence. However, the
length (6-14 amino acids) and the relative hydrophilicity of this region is important for
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both GPI-T recognition and consequent GPI anchoring (111,115-117,121,122). In
addition, spacer region may have a role in locating the ω site to the active site of
GPI-T(122).

1.1.2c The Hydrophobic Region
The C-terminal hydrophobic region is the third key element of the GPI-T
signal sequence. The overall hydrophobicity and the length of this region are critical
parameters for the proprotein substrate to be recognized and anchored by GPI-T
(123-126). Truncations and point mutations that diminished the hydrophobicity of the
C-terminal region both eliminated GPI anchoring (57,117,124,125). The remarkable
ability of the Ser3-Thr8-Leu14 to direct GPI anchoring further revealed that
hydrophobicity is the driving feature of this region (117,127). In addition to the
importance of this region for GPI-T to recognize the proprotein substrate, it is also
involved in targeting the propeptide to GPI-T. For this purpose, during the GPI
transamidation, the C-terminal hydrophobic region temporally anchored to the inner
leaflet of the ER membrane. This attachment facilitates the proper orientation of the
ω region residues at the active site of GPI transamidase (122,127).
Overall, the complete GPI-T signal sequence is not a consensus sequence
but rather a pattern of small, hydrophilic and hydrophobic residues. However, amino
acid variations in the GPI signal sequence of GPI-APs and along with active site
variations in GPI-T likely contribute to the apparent substrate and species specificity
exerted by GPI-T (128-131). In addition to the role of this signal sequence for
directing the attachment of precursor proteins to the GPI anchor, GPI-T signal
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sequence also have a role in regulating the confirmation and function of its precursor
proteins (132). This phenomenon was investigated using Als5 protein of Candida
albicans, a GPI anchoring protein. The study revealed that the Als5 proteins with
and without GPI signal sequence acquire two different confirmations with functional
variations (132).

1.2 The GPI Transamidase Complex
The discovery of GPI anchors and GPI-APs was followed by an array of
investigations to elucidate the GPI anchoring process and to identify the enzyme that
mediates it. Evidence suggesting that the putative enzyme is a transamidase arose
from a series of in vivo and in vitro experiments (103-105,133-136). These findings
revealed that the enzyme, now called GPI transamidase or GPI-T, proceeds via
formation of an activated carbonyl intermediate, like a protease. The intermediate is
susceptible to immediate nucleophilic attack by a GPI anchor (or a suitable
nucleophile donor under artificial conditions) and reaction happens without any
energy source. Further, the process required only a single enzyme confirming that
GPI-T is indeed a transamidase.
GPI-T is localized in the ER as multimeric protein complex (137). There are
five protein components that make up the GPI-T complex (Figure 1.6) (1,138).
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Figure 1.6 The GPI-T complex. The predicted transmembrane domains for
each subunit are shown as rectangles spanning the ER membrane bilayer, which
is represented in light grey. The subunits in black are found in all eukaryotes,
whereas the subunits in dark grey are found in humans and yeast, but not in
trypanosomes.
The subunits Gpi8, Gpi16, Gaa1, Gpi17, and Gab1 are found in yeast and
their respective homologues, PIG-K, PIG-T, GPAA1, PIG-S and PIG–U, are found in
humans (1). The subunits, Gpi8, Gpi16, and Gaa1, are ubiquitous in eukaryotes,
however, Gpi17 and Gab1 are absent from trypanosomes (139), where they are
replaced by two unique subunits - TTA1 and TTA2 (139). TTA1 and TTA2 have no
sequence homology to Gpi17 and Gab1. However, they possess similar membrane
topologies.

1.2.1 The Subunits of GPI-T
Identification of the GPI-T subunits was challenging and utilized a
combination of genetic, molecular biology and biochemical approaches. Gaa1 and
Gpi8 were the first subunits identified. Co-immunoprecipitation experiments lead to
the identification of rest of the GPI-T subunits including Gpi17, Gab1 and Gpi16
(138,140,141). In S. cerevisiae the subunits Gaa1 and Gpi16 co-immunoprecipitate
with GST tagged Gpi8 forming a heterotrimeric complex (138). The subunits Gpi17
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and Gab1 of S.cerevisiae do not interact with the heterotrimeric complex and exist
as a heterodimer (140). In humans expression of FLAG-GST-hGPI8 lead to coimmunoprecipitation of subunits GPAA1, PIG-S and PIG-T (141). Further, in humans
it is also revealed (via mutational analysis) that the GPI-T complex to be functional it
should also associate with PIG-U. Thus, in contrast to S.cerevisiae GPI-T, human
GPI-T exists as a heteropentamer.
The gene GPI8, which encodes for Gpi8, was first identified from
Saccharomyces cerevisiae using a temperature-sensitive (TS) mutant strain (142).
This strain is unable to express GPI anchored proteins on the cell surface but
produced full-length GPI anchors. However, when transformed with yeast
chromosomal DNA, GPI anchoring activity was restored and the complementing
gene was identified as yGPI8 (143). In yeast, deletion of this gene is indicating that
GPI anchoring is an essential function in yeast (143).The human homologue of
GPI8, hGPI8 was isolated using a similar genetic approach to that of yGPI8 (143).
The class K mutant strain, lacking a functional hGPI8 gene, efficiently expressed
mature GPI anchors but was unable to produce GPI-APs (144,145). yGPI8 was able
to restore GPI anchoring activity in the class K cell line, indicating that yGPI8 and
hGPI8 are homologues (145). A forward genetic approach was used to identify the
corresponding GPI8 gene in trypanosomes. Mutation of trypanosomal GPI8 was not
lethal; however, it affected pathogenesis (146) due to the lack of GPI anchored
protein procyclin. In T.brucei GPI anchored procyclin act as a protease-resistant
protective coat against enzymes secreted from the midgut of tsetse fly. This
protection is important for T.brucei survival and to establish infections (14,146,147).
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In yeast and humans, Gpi8 is a type I transmembrane protein with a large
lumenal domain and a single transmembrane (TM) domain (138,143,145). In
protozoans, Gpi8 is soluble and does not contain a TM domain (148,149), hinting
that the Gpi8 TM domain is not involved in Gpi8‟s function (150). Gpi8 is a 47 kD
protein with 25–28% sequence homology to a family of cysteine proteases,
especially to that of C13 family (138,151). In addition, the active site of Gpi8 shows
weak sequence similarity to caspases, especially to caspase-1 (151). Recent work
by our group demonstrated that Gpi8 has organizational similarity to caspases as
well as it undergoes homodimerization (152). The enzymatic contribution of Gpi8
towards GPI transamidation was investigated using several reporter assays
(150,153-155). The production of GPI-anchored VSG was restored in Gpi8-depleted
T. brucei ER membranes by the addition of recombinant Leishmania mexicana Gpi8
(150), indicating the direct contribution of Gpi8 towards GPI anchoring of
proproteins. Gpi8‟s role in the proteolytic processing of proprotein substrates was
confirmed in an in vitro fluorescence assay, which utilized a fluorogenic peptide
substrate acetyl-S-V-L-N-aminomethyl-coumarine (153). Recombinant TbGpi8 was
able to process this synthetic substrate, causing an increase in coumarine
fluorescence. Gpi8 was also observed to be physically associated with precursor
protein substrate prominiPLAP in an assay performed with semi-permeabilized K562
cells. This association was not observed when the assay performed with GPI8
knockdown class K mutant cell line (155).
The active site of Gpi8 was preliminarily identified based on its sequence
homology to cysteine proteases (the C13 family of cysteine proteases and caspase-
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1). These proteases carry a cysteine:histidine catalytic dyad and use a general
acid/base catalytic mechanism to cleave substrate proteins (156,157). All forms of
eukaryotic Gpi8, including yGpi8, hGpi8 and LmGpi8, had conserved cysteine and
histidine residues (148,151,158). The conserved residues were investigated using
mutagenic analysis to identify the putative Cys:His pair for catalysis. For instance,
yGpi8 contains two conserved cysteine residues (C85 and C199) and two histidine
residues (H57 and H54) (151). These residues were individually mutated to alanine
and analyzed for their ability to promote GPI anchoring activity in GPI8 depleted cell
lines or in TS strains. The expression of yGpi8, containing C199A or H57A point
mutations, did not have GPI anchoring activity, suggesting that these positions make
up the putative catalytic dyad. Similarly, in human cells, mutation at the potential
amino acids C92, H164 and C206 revealed that H164 and C206 comprised the
catalytic dyad (158). In trypanosomes, conserved residues H174 and C216 are
responsible for catalysis (148). These results revealed that Gpi8 is the catalytically
active subunit of GPI-T. However, it is catalytically inert in the absence of other GPIT subunits (152).
The gene encoding Gaa1, GAA1, was first identified from a temperature
sensitive S. cerevisiae strain using similar methods as described for yGPI8 (159).
These strains were unable to incorporate metabolically labeled GPI (containing [ 3H]
inositol) onto Gas1p, a known GPI-AP. Complementation with a plasmid carrying
yGAA1 restored GPI anchoring activity and mature Gas1-GPI was detected by SDSPAGE. Based on these evidences, Gaa1 is important to incorporate GPI anchor to
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GPI anchoring proteins. The corresponding human (158,160,161) and trypanosomal
(139) GAA1 were identified based on sequence similarities to that of yGAA1.
Gaa1 is an ER-oriented protein with several C-terminal transmembrane
domains (TM), a large lumenal domain and a single N-terminal transmembrane
domain (Figure 1.6) (149). Yeast Gaa1 is a 70 kD protein with six TM domains, while
human Gaa1 is a 68 kD protein with seven TM domains (149). The structurefunction relationship of different Gaa1 domains were analyzed using C-terminally
truncated human Gaa1 mutants (162,163). According to these studies, the large
lumenal domain of Gaa1 is sufficient to interact with other subunits in the GPI-T
complex. However, the assembled GPI-T complex was functionally defective in the
absence of the C-terminal TM domains of Gaa1. Immunoprecipitation studies also
revealed that this GPI-T complex could still interact with proprotein substrates but
not with the GPI anchor (162). Further experiments revealed that the last TM domain
of Gaa1 likely interacts directly with the GPI anchor. This interaction is important as
it facilitate recruitment of GPI to GPI-T in order to participate in GPI transamidation.
A conserved proline residue in this last Gaa1 TM domain has been proposed to act
as a dynamic hinge during requirement of the GPI anchor (163).
In 2001, two new GPI-T subunits, named Gpi16/PIG-T and Gpi17/PIG-S were
identified from yeast and humans (138,141). The expression of a glutathione-Stransferase (GST) tagged GPI8 in a GPI8 knockout S. cerevisiae strain enabled
affinity purification and characterization of GPI-T (138). SDS-PAGE analyses of this
protein complex, followed by silver nitrate staining, revealed three distinct bands
(138). Tryptic digestion followed by mass spectroscopy identified these bands
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correspond to proteins GST-Gpi8, Gaa1, and a new protein YHR188c, which was
later named Gpi16 in yeast. In a similar manner, the expression and affinity
purification of FLAG-GST-hGPI8 in GPI8-depleted class K mutant cells led to the coprecipitation of four proteins (141). The proteins co-precipitated with Gpi8 include
Gaa1 and two new proteins. The two new proteins were later named PIG-S and
PIG-T (141).
Gpi16/PIG-T is a type 1 transmembrane protein with an N-terminal ER
localizing sequence, a large lumenal domain, and a C-terminal transmembrane
(138). Yeast Gpi16 is a 69 kD protein (138). Its homologues from other eukaryotic
organisms have a similar hydrophobicity profile with amino acid lengths that vary
from 531-639 amino acids (141,164). Treatment of Gpi16 with endoglycosidase H
(Endo H) caused a decrease in observed mass revealing that Gpi16 is a
glycoprotein with two N-glycosylation sites (138). Mutational studies with human
GPI8 and PIG-T (the human GPI16 homolog) revealed the existence of a disulfide
linkage between these two subunits (164). Upon expression of GST- GPI8C92S in
GPI8-deficient class K mutant cells, co-immunoprecipitation of PIG-T with Gpi8 was
disrupted. Similarly the mutant PIG-TC182S did not interact with Gpi8 indicating the
existence of a disulfide linkage between Cys192 of Gpi8 and Cys182 of PIG-T. This
disulfide bond might form a funnel that gates the access of proteins to the active
site of Gpi8 (164). However, GPI-T containing either GPI8C92S or PIG-TC182S in
ΔGPI8 or ΔPIG-T mutant cell lines, respectively, was capable of producing trace
amounts of mature, GPI-anchored miniPLAP (164). Hence, this covalent interaction
is important, but not essential for GPI anchoring activity. Further Gpi16 is involved
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in stabilizing the GPI-T as depletion of Gpi16 led to reduced expression of GPI-T
subunits, Gaa1 and Gpi8 (141).
Gpi17 is a 61 kD, glycosylated transmembrane protein (140). Its large soluble
domain is lumenally oriented (140) and flanked by two transmembrane domains so
that both the N and C termini of Gpi17 are cytosolically oriented (140). In humans,
PIG-S (the human GPI17 homolog) is associated with the rest of the GPI-T subunits
in stoichiometric ratios (141). In contrast, no stoichiometric level association is
observed between yeast Gpi17 with subunits Gpi8, Gaa1 and Gpi16 (140).
Even though the exact functions of Gpi16/PIG-T and Gpi17/PIG-S are not
known, these two subunits are essential to the GPI anchoring process (141).
Depletion of either subunit causes accumulation of GPI anchor and proprotein,
indicating a dramatic reduction in GPI-T activity. Gpi16 is sensitive to depletion of
other GPI-T subunits (140). Further Gpi16 and Gpi8 depend on each other for
stability (138). In contrast, Gpi17/PIG-S stability and its GPI anchoring function is
slightly affected only with Gaa1 depletion (140). These observations suggest that
Gpi17 might not be part of the catalytically functional unit of yeast GPI-T.
PIG-U/Gab1 is the fifth GPI-T subunit. PIG-U was first identified from a
chemically mutated Chinese hamster ovary (CHO) cell line that was deficient in cell
surface expression of GPI anchored proteins (165). Transfection with genes
corresponding to any of the known human GPI-T subunits did not restore the GPI
anchoring activity. This observation indicated the need for another subunit.
Complementation with a rat cDNA expression library led to the identification of the
complementing gene PIG-U and hence the fifth subunit of GPI-T. Nearly
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simultaneously, the corresponding yeast subunit Gab1 was identified from a yeast
strain defective in cellular morphogenesis (166).
Gab1 is a 38 kD, highly hydrophobic protein with several transmembrane
domains and a very small putative soluble domain (~50 amino acids). The number of
estimated TM domains varies between 8 and 10. Due to the high hydrophobicity of
Gab1 and its sequence similarity to that of fatty acid elongase, it has been
speculated that Gab1 might be involved in recognizing the fatty acid in the GPI
anchor, presenting it to the active site of Gpi8 (165). This was supported by the fact
that in humans, the GPI-T complex can assemble in the absence of PIG-U, but it is
non-functional in GPI anchoring of proprotein substrates (165).
With the identification of the subunit Gab1, we now able to predict the
structural arrangement of GPI-T complex to a certain extent. In humans expression,
and two step affinity purification of FLAG-GST-hGPI8 revealed that the subunits,
PIG-T, GAA1, PIG-U and PIG-S co-immunoprecipitate with PIG-K confirming
human GPI-T is a pentamer. In contrast, yeast GPI-T complex composed of two sub
complexes a heterotrimer (138) and a heterodimer (140,166). In trypanosomes, GPIT consists of five subunits. Three of the trypanosomal subunits are homologues to
subunits Gpi8, Gaa1 and Gpi16 while Gab1 and Gpi17 are replaced with two
unrelated subunits TTA1 and TTA2 (139). Overall, the subunits Gpi8, Gaa1 and
Gpi16 are found in all forms of GPI-T. Therefore, we can speculate that these
subunits are the core components of GPI-T complex. However, in the absence of
experimental data with a pure soluble form of GPI-T we cannot draw conclusions
about the GPI-T structure.
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1.2.2 The Mechanism of GPI Transamidation
Gpi8/PIG-K is the catalytically active subunit and its sequence homology to
cysteine proteases led to propose the mechanism of GPI transamidation.
Mutagenetic studies revealed that Gpi8/PIG-K contains conserved cysteine and
histidine residues that are essential for activity and presumably comprise the
catalytic dyad (148,151,158). In addition, different experiments revealed that the
Gpi8 is physically interacting with the proprotein substrate via a thioester
intermediate (150). For instance, the conversion of pro-VSG to VSG-hydrazine by L.
mexicana His-tagged Gpi8 in a cell free system was abolished by treatment with the
thiol alkylating reagent iodoacetamide providing evidence for the formation of a
thioester intermediate (150). These results supported the similarity between
mechanisms of cysteine protease with that of GPI-T. The only difference is that GPIT uses the GPI anchor instead of water to complete the reaction (Figure 1.7).
According to the proposed mechanism, the histidine residue acts as a base to
deprotonate the cysteine thiol. The thiolate nucleophilically attacks the carbonyl
carbon of the ω amino acid, forming a thioester and releasing the C-terminal signal
sequence. Consequently, a second nucleophilic attack, by the free amine of the
ethanolamine in the GPI anchor, cleaves the thioester bond to form an amide
linkage between the GPI anchor and the protein.
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Figure 1.7 The proposed reaction mechanism for GPI-T. Deprotonation of
the catalytic cysteine residue by histidine facilitates the nucleophilic attack,
formation of a thioester bond and release of the C-terminal GPI-T signal
sequence. A secondary nucleophilic attack by the free amine of EtNP cleaves
the thioester bond and forms a new amide bond between the protein and the
GPI anchor.

1.3 The GPI Anchored Proteins (GPI-APs)
In eukaryotes, proteins can associate with the extracellular membrane via
different means. GPI anchoring of proteins offers one method that is distinct from
lipidation or the addition of transmembrane domains GPI anchoring proteins are cotranslationally translocated to the ER lumen as preproproteins. At ER the N-terminal
ER localizing signal sequence is cleaved by signal peptidase. The resulted
proprotein then undergo GPI transamidation at the inner leaflet of the ER to produce
GPI anchored proteins (107-110). GPI-APs are typically transported through the
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secretory pathway to the extracellular membrane and perform a diverse set of
physiological functions as detailed below.

1.3.1 Intracellular Transport of GPI-APs
GPI-APs attached to the inner leaflet of the ER membrane, exit the ER and
are transferred to the extracellular membrane via the Golgi network. During this
journey, the GPI anchor plays a major role as a sorting signal. First, it functions as
an ER exit signal (167-169). Next, in the Golgi, it acts as a sorting signal in
combination with other sorting signals from the attached protein to direct the GPIAPs to different domains of the cell membrane. In order to act as a signal, the GPI
anchor in GPI-APs undergoes two structural modifications (170). These include the
removal of the acyl chain linked to the inositol ring of the GPI anchor (a reaction
catalyzed by inositol deacylase) and the removal of the EtNP attached to the second
mannose in the anchor (171,172). Inability to perform either of these modifications
lead GPI-APs to accumulate in the lumen of the ER followed by degradation.
GPI-APs with suitable export signals leave the ER at ER-exit sites (ERES)
and are transported to the Golgi via coat protein complex II (COPII) vesicles (173).
GPI-APs lack transmembranes; as a result, there is no direct loading of GPI-APs to
COPII vesicles. Hence, cargo receptors (p24 family protein complex) are needed
(174). These receptors first interact with GPI-APs at ERES. Then these GPI-AP
loaded cargo receptors concentrate into COPII vesicles. Upon transportation to the
cis-Golgi compartment the cargo receptors load GPI-APs into the golgi complex and
then they dissociate from the GPI-APs, a process that is mediated by pH changes.
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The cargo receptors are then recycled back to ERES via coat protein complex I
(COPI) vesicles (173) to initiate another cycle.
The sorting mechanisms in the trans Golgi network determine the final
destinations of different GPI-Aps (apical vs. basolateral domains of the plasma
membrane) (175-177). However, this process remains poorly understood. Most GPIAPs are ultimately localized to the apical domains of the plasma membrane (177).
Originally it was suggested that the GPI anchors of GPI-APs act alone as apical
sorting signals (175,176). Later it was shown that at trans Golgi network fatty acid
remodeled GPI-APs are recruited to the lipid micro domains/lipid rafts. This lipid
raft/GPI-AP combination may act as an apical sorting signal (178). Here, saturated
fatty acid chains in the PI of the GPI anchor interact with ceramides in the lipid rafts.
Recently it was shown that recruitment of GPI-APs to lipid rafts further facilitate the
oligomerization of GPI-APs via its protein domains and hence provide a combined
effect for apical sorting machinery operated within the trans golgi network (179,180).
It has also been proposed that the N-glycans and O-glycans on GPI-APs also can
act as apical sorting signals to direct GPI-APs from the Golgi to plasma membrane
(181,182). However there exist contradictory opinions towards the roles of these
glycans (183).
In fungi, certain GPI-APs are ultimately covalently integrated into the cell wall
(7). For instance, in S. cerevisiae, the first mannose (Man1) residue, immediately
adjacent to the GlcN-PI in the GPI anchor, forms a new glycosidic linkage with β1-6
glucan in the yeast cell wall (184). This process removes the GlcN-PI of the GPI
anchor. As a result, the cell wall anchored protein has a common core structure of
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protein-CO-NH-(CH2)2-PO4-(Man4)-Man3-Man2-(EtNP)-Man1-glucan. Certain amino
acids N-terminal to the ω site residue participate in determining whether or not a
fungal GPI-AP remains in the plasma membrane or is transferred to the cell wall.
Basic amino acids close to and upstream of the ω site direct the GPI-APs to the
plasma membrane (185,186). However, the presence of valine, isoleucine, or
leucine at ω-4 or ω-5 and tyrosine or asparagine at ω-2 directs yeast GPI-APs to the
cell wall (186). In addition, serine/threonine rich regions further upstream to the ω
site also favor cell wall integration of yeast GPI-APs (187).

1.3.2 Functions of GPI-APs
In eukaryotic organisms GPI-APs perform a wide variety of roles as enzymes,
structural components (188,189), complement regulators (190), adhesion molecules
(191), receptors (192,193), signaling molecules,(194-196) etc. In yeast, GPI-APs are
important to maintain cell wall stability and cell morphology. The S. cerevisiae
protein Gas1p is a β1, 3-glucan specific transglucosidase that is essential for cell
wall assembly (188). Further many GPI-APs are attached to the yeast cell wall and
contribute to maintain stretch resistance and osmotic stability (189). GPI-APs also
function as cell surface receptors, including nutrient uptake receptors, toxin
receptors, etc. In humans, the uptake of folate is performed by GPI anchored folate
receptors. However, the folate receptors also function as receptors for viruses such
as Ebola virus (EBV) (192). In parasitic protozoa, the high density of GPI-anchored
glycoproteins acts as a protective coat to protect parasites against the immune
responses from the host (8). GPI-APs are engaged in mediating the immune
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response. For instance, the GPI anchored protein DAF regulates the T cell mediated
immune response. DAF also acts as complement regulator, to prevent complement
activation and hence to protect cells from complement attack (197).

1.4 The Role of GPI-T in Disease Progression
GPI-T mediates important post-translational modifications in eukaryotic
organisms to produce GPI-APs. In addition to this primary role, GPI-T is also
involved in disease progression, especially in relevance to cancer. In humans, the
non-catalytic GPI-T subunits, PIG-U, GPAA1 and PIG-T, have been identified as
oncogenic (9-11,198). Overexpression and copy number variations have been
observed for these subunits in a wide variety of cancer tissue samples including
breast, bladder, ovarian, colon, lung, head and neck cancers (11,198). These
subunits may be involved in cancer progression as individual subunits or as a group
with variable composition. For instance, PIG-U was identified as oncogenic in human
bladder cancer (11). In addition, overexpression of PIG-U with other oncogenic GPIT subunits, Gaa1 and PIG-T induced tumorigenesis and invasion of human breast
cancer in mice, suggesting a combined contribution of these subunits (10,198).
However, despite these observations, GPI-T‟s role in cancer progression is not yet
resolved.
GPI-T also plays a very important role in pathogenic diseases. In parasitic
protozoa, the VSG is presented at the outer leaflet of the cellular membrane via its
GPI anchor. VSG helps parasites evade the host immune system (199). Because
parasitic protozoan carry two different GPI-T subunits instead of Gab1 and Gpi17
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(TTA1 and TTA2), these differences could be useful to develop therapeutic agents
against pathogenic diseases such as African sleeping sickness and leishmaniasis
(199,200). GPI-T also has a role in prion disease pathogenesis. GPI-anchored
normal prion proteins (PrPc) are located on the host cell surface. These PrPcs
interact with aggregates of disease associated prion proteins (PrP sc) (201). This
interaction converts normal host cell PrPc to pathogenic PrPSC, leading to the
progression of prion and related diseases (201). However, contradictory evidence
from cell free assays and transgenic mice studies reveal that non-GPI-anchored
PrPc can also be converted to PrPsc (202-204). Hence, this phenomenon needs to
be further investigated.

1.5 Dissertation Research Summary
This dissertation describes our efforts towards understanding various aspects
of S. cerevisiae GPI-T and its transamidation reaction. In this research, for the first
time in the GPI-T field, a pure solubilized form of S. cerevisiae GPI-T was used
(instead of crude microsomes) in an in vitro assay to characterize GPI-T.
Chapter 2 details the development and optimization of a in vitro kinetic
fluorescence resonance energy transfer (FRET) assay for GPI-T. A time dependent
fluorescence response was observed upon incubating the proprotein substrate with
pure, solubilized S. cerevisiae GPI-T in a nucleophile-dependent manner. Various
optimization experiments were used to further enhance the observed fluorescence
response. In addition, experiments were conducted to identify and analyze GPI-T
cleaved assay products.
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Chapter 3 explains the use of this FRET assay for GPI-T to characterize
various aspects of GPI transamidation. Experiments were performed to understand
the effect of identity elements in the GPI signal sequence towards peptide substrate
recognition by GPI-T. The assay was also utilized to investigate the species-specific
substrate selectivity of GPI-T Further; the new assay was utilized to identify
cofactors and inhibitors affecting the catalytic activity of GPI-T.
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Chapter 2
Development and optimization of an in vitro FRET assay to characterize the
Saccharomyces cerevisiae GPI-T
2.1 INTRODUCTION
The formation of glycosylphosphatidylinositol (GPI) anchored proteins (GPIAPs) is an important post-translational modification mediated by GPI-T. Many
methods including in vivo, in vitro and computational analyses are being utilized to
elucidate

various

aspects

of

GPI-T

and

its

transamidation

reaction

(103,104,111,112,114,115,119,120,123,131,137143,145,146,148,150,151,153,154,158-162,165,166,205-214). Experiments based
on these methods facilitated the identification of the GPI-T subunits (138143,145,146,148,151,158-162,165,166,205)(20) and defined the protein substrate
parameters

(111,119,131,206,208)

the

GPI

anchoring

mechanism

(103,104,111,114,120,137,150,153,154,209-215), etc. However, the majority of
these experiments used qualitative approaches. So far, only one quantitative in vitro
assay has been developed to characterize GPI-T (153). However this assay is
accompanied with serious limitations (refer to section 2.1.2.b). To date no one has
successfully reconstituted GPI anchoring activity in vitro using a pure solubilized
GPI-T. Further, quantitative assays to kinetically analyze the catalytic activity of GPIT have not been reported. As a solution to this ongoing problem, this chapter
describes the development and optimization of the first high-throughput, in vitro
fluorescence resonance energy transfer (FRET) assay to characterize the catalytic
activity of GPI-T.
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2.1.1 In Vivo Assays for GPI-T
Most of the in vivo assays developed so far have been based on genetic
methods

(139,142,143,145,146,148,151,158-161,165,166,205),

immunoprecipitation

(138,140,141,162),

flow

cytometry

co-

(165)

and

immunofluorescence microscopy (124) (see Chapter 1). The major drawback of
these in vivo assays is the inability to study GPI transamidation alone without impact
or contribution from other cellular components. This issue limits the types of
experimental questions that can be addressed. The following sections present brief
descriptions of the in vivo assay methods that have been most successfully applied
to the study of GPI transamidation.

2.1.1a The PreproPLAP Assay
In vivo assays were conducted with placental alkaline phosphatase (PLAP), a
human GPI anchored protein, to elucidate various aspects of GPI-T catalysis. COS
cells were transfected with wild type and mutant cDNA copies of the ALPP gene
(encoding PLAP). GPI anchoring of the expressed PLAP protein was analyzed by
SDS-PAGE, Western blots and for its sensitivity to phosphatidylinositol specific
phospholipase C (PI-PLC). PLAP was used to identify the key identity elements in
the

GPI-T

signal

sequence,

amongst

other

significant

discoveries

(111,119,206,208). Overall, these experiments revealed that the C-terminal GPI-T
signal sequence is not a consensus sequence and the amino acid composition can
vary as long as it meets general charge, hydrophobicity and length requirements.
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2.1.1b The Invertase Assay
Recently, a novel in vivo assay was developed by members of the
Hendrickson group to investigate GPI-T and the possibility of species specificity
(131). The C-terminal GPI signal sequence of two human GPI-APs, the campath-1
antigen (CA26) and the urokinase-type plasminogen-activated receptor (UP30) and
an S. cerevisiae GPI-AP, Yapsin 2 (Y21), were appended individually onto the Cterminus of the yeast secretory protein invertase (INV) (Figure 2.1, (131)).

Figure 2.1 Species specificity of S. cerevisiae GPI-T. (A) Strategy to produce
invertase reporter proteins as substrates for S. cerevisiae GPI-T. The C-terminus of
full-length soluble invertase (INV) was modified by appending GPI-T signal
sequences from yeast Y21, human CA25 and human UP30 separately. (B) An in vitro
colorimetric assay was used to measure the S. cerevisiae cell surface expression of
invertase (INV-Y21, INV-CD52 and INV-UP30). The construct INV-Y21 demonstrated
the highest level of cell surface invertase activity, consistent with yeast GPI-T favoring
the fungal Y21 signal sequence. Figure courtesy of Dr. Rachel Morissette

Cell (S. cerevisiae) surface expression levels of GPI anchored INV were
monitored using a colorimetric assay and biochemical partitioning. This assay
demonstrated that GPI anchoring of human-INV constructs were diminished
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compared to that of INV with the yeast GPI signal sequence. Although only a small
number of signal sequences were tested, these results suggested that GPI-T has
some ability to recognize sequences according to species.

2.1.2 In Vitro GPI-T Assays
In vivo assays contributed greatly to our understanding of GPI-T and its
transamidation reaction as detailed in section 2.1.1. and as reviewed in Chapter 1.
However, in vivo experiments performed in intact cells obscure a mechanistic view
of the GPI-T reaction, due to the complicated nature of the cellular environment. To
overcome this challenge, several efforts have been made to develop cell free
methodologies

to

study

the

catalytic

activity

of

GPI-T

(103,104,111,114,120,137,150,153,154,209-215). The following sections provide
brief descriptions of theses assays and how they have contributed to GPI-T
research.

2.1.2a The PreprominiPLAP Assay
The preprominiPLAP assay is the most widely used in vitro assay to study
GPI-T (Figure 2.2, (114,216)) (103,104,114,120,137,154,211-213). This cell free
assay was developed by coupling rough microsomes (RMs) to an in vitro translation
system, which translates preprominiPLAP mRNA. As in intact cells, the N-terminal
signal peptide is cleaved from preprominiPLAP to produce prominiPLAP, the
substrate for GPI-T. The processing of prominiPLAP by GPI-T, to GPI anchored
miniPLAP, is monitored by SDS-PAGE and Western blot.
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Figure 2.2 The miniPLAP assay to monitor GPI-T activity in vitro. (A) The crystal
structure of the full length PLAP (PDB ID: 1ZEB).NTS and GPI-T-S represent the Nterminal ER localizing and C-terminal GPI-T recognition signal sequences, respectively.
(B) A cartoon schematic representing the stepwise conversion of preproPLAP to
different miniPLAP derivatives, including free miniPLAP and the GPI anchored, mature
miniPLAP. The preprominiPLAP construct was designed by deleting a majority of the
protein‟s internal sequence. A poly methionine (Poly-Met) region was incorporated for
35
S labeling. (C) A cartoon schematic of an SDS-PAGE gel showing the stepwise
conversion of preprominiPLAP to different forms of miniPLAP.
Adapted with permission from Varma, Y., and Hendrickson, T., Chembiochem, (2010),
11, 623-636, with permission from John Wiley and Sons.

This miniPLAP assay was utilized extensively to investigate many aspects of
the GPI transamidation reaction. Some of these findings include the analysis of the
sequential conversion of the preproprotein to a mature GPI anchored protein
(103,104,114), the cellular localization of GPI-T (137), GPI-T signal sequence
requirements (114,120,211) and the interaction of GPI-T subunits with proprotein
substrates (154,212). Despite these credible efforts, the miniPLAP assay is also
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accompanied with limitations such as the use of crude RMs instead of pure GPI-T
and the inability to use synthetic peptide substrates. Thus, the preprominiPLAP
assay remains fairly qualitative as a method to analyze GPI-T.

2.1.2b A Fluorescence Assay for GPI-T
The ability of T. brucei Gpi8 to mediate the transamidation reaction (150), the
acceptability of small nitrogen nucleophiles (214) and a short, synthetic peptide
substrate for GPI-T were critical in the development of the first specific cell free
assay (Figure 2.3,(153)) (153).

Figure 2.3 An in vitro assay to quantitatively characterize GPI-T activity. Incubation of
a fluorescently labeled, synthetic tetrapeptide (Ac-SVLN-AMC) with trypanosomal lysates
results in enhanced fluorescence with a shift in the emission maximum. (A) Ac-SVLN-AMC
is based on the cleavage and anchor attachment site of VSG. (B) Incubation with
trypanosomal lysates leads to cleavage of the terminal amide bond in the peptide substrate,
resulting in a shift in emission maximum from 400 nm to 440 nm (▼), compared to peptide
alone (▲), lysate alone (●), or buffer alone (■). (C) The addition of 10 mM hydrazine
enhances AMC release (■), compared to lysate with substrate alone (●) or peptide
substrate alone (▲). Incubation was for 24 hours. Adapted with permission from kang et al.,
J. Cell. Sci. (2002) 115, 2529-2539 with permission from the Company of
Biologists.
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A

fluorescently

labeled

synthetic

tetra

peptide

(Ac-SVLN-AMC;

AMC=aminomethylcoumarin), based on the ω-3 to ω region amino acids of T. brucei
VSG, was used as the peptide substrate for this assay. Incubation of this peptide
with either trypanosomal lysates or pure T. brucei Gpi8 alone resulted in cleavage of
the C-terminal amide bond, releasing aminomethylcoumarin. Cleavage was
monitored by following the shift in fluorescence emission maximum for free AMC
compared to the stating peptide. Addition of hydrazine further enhanced the
fluorescence

intensity,

while

a

sulfhydryl-alkylating

agent,

p-

chloromercuriphenylsulfate (pCMPSA) abolished the reaction, presumably by
modifying the active site cysteine in Gpi8. Even though this assay laid the foundation
for the development of more quantitative GPI-T in vitro assays, it is also associated
with serious limitations including an apparent requirement for a long incubation
period (24 hours) and the use of a minimalistic version of a proprotein substrate that
lacks the GPI-T signal sequence. In theory, a significant feature of this assay is the
ability to measure changes in fluorescence over time, which gives quantitative
results, compared to the qualitative in vitro assays discussed so far. In practice, the
small fluorescence change over time is expected to limit its application. In fact, the
2002 publication describing this assay (153) remains the only application of this
method to the study of GPI-T.
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2.1.3 A New High Throughput In Vitro FRET Assay for GPI-T
As detailed in sections 2.1.1 and 2.1.2, previous efforts to characterize the
structure and catalytic activity of GPI-T were mostly limited to qualitative analyses
(129,138). Efforts to study GPI-T in a quantitative way have been very limited (153).
These discoveries alleviated the challenges faced when using co-translational
systems and rough microsomes. Despite these forays, no one has yet successfully
reconstituted the GPI anchoring activity in vitro with purified enzyme. In addition, no
high throughput quantitative methods are available to analyze pure GPI-T in vitro.
For this reason, many questions remain with respect to understanding GPI-T, its
catalytic function, and its physiological roles in healthy and abnormal cells. For
instance, we cannot be certain how many subunits are necessary for GPI-T to exert
catalytic activity. In other words, is GPI-T the heterotrimer that can be co-purified
from yeast (138) , or is it the heteropentamer that is isolated from human cells (141)
? Hence, the Hendrickson lab stepped forward to develop a high throughput in vitro
FRET assay for GPI-T.
Our GPI-T assay was designed to measure the restored fluorescence of a
fluorophore upon hydrolysis of the scissile amide bond at the ω site in a synthetic
proprotein substrate. This substrate was designed so that the proprotein would have
minimal fluorescence based on the presence of an appropriate quencher; upon
cleavage by GPI-T, the fluorophore and quencher would be separated, enhancing
fluorescence. We choose aminobenzoic acid (Abz) as the fluorophore and a 3nitrotyrosine (Y*) as the quencher (Figure 2.4). We envisioned that incubation of this
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peptide with a source of GPI-T and a nucleophile donor would result in an increase
in fluorescence over time in a manner that would correlate to GPI-T activity.

Figure 2.4 Cartoon schematic of our GPI-T fluorescence assay. GPI-T is expected
to cleave the scissile amide bond in the synthetic, propeptide substrate to restore Abz
fluorescence. This assay could use full-length GPI anchor or small GPI anchor mimics
like hydroxylamine or hydrazine as the nucleophile donor.

2.2 RESULTS
2.2.1 Design and Synthesis of Peptide Substrates for the In Vitro Assay
The human Campath–1 (CD52) antigen was chosen as the basis for a
synthetic peptide substrate for GPI-T. This 37 amino acid peptide is the smallest
known eukaryotic substrate for GPI-T; after processing, the GPI anchored peptide is
only 12 amino acids long (217-219) . The wild type sequence of the CD52 proprotein
is shown in Table 2.1. Certain modifications were introduced into this sequence to
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avoid adverse effects of N-linked glycosylation with crude microsomes and oxidation
during peptide synthesis. Both Asn3 and Asn16 were changed to lysine avoid Nlinked glycosylation issues and to increase the solubility of the peptide (220). The Cterminal Cys35 was mutated to histidine to avoid peptide oxidation via disulfide bond
formation. Cysteine was mutated to histidine, as His frequently appears in the
hydrophobic region of GPI anchoring proteins(129). Peptide 1 (Table 2.1) was
capped with Abz and the 3-nitrotyrosine quencher was added in place of Ile17.
Peptide 1 (Table 2.1) had more than one potential ω site leading to concerns
about ambiguity in product formation during our GPI-T assay. Therefore, peptide 2
(Table 2.1) was designed by replacing Thr8 and Ser15 with lysines, optimizing
Ser12 as the most viable ω site. Finally, in order to evaluate the peptide products
from our assay, a biotinylated version of peptide 2 (peptide 3, Table 2.1) was also
synthesized; the biotin was attached to the side chain of Lys3. For peptides 1, 2 and
3 Abz (fluorophore) was coupled to the N terminus Gly1 and Ile17 was replaced by
3-nitrotyrosine (quencher). Peptides 1 and 2 were first synthesized using automated
peptide synthesis as per the standard protocols of Fmoc solid phase peptide
synthesis. Peptides 2 and 3 were also synthesized by manual peptide synthesis.
Digestion of peptide 1, 2 and 3 with Trypsin revealed that peptides are internally
quenched; hence sufficient to produce a readily visible fluorescence change upon
incubation with GPI-T(221).
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Table 2.1 Peptide substrates for the GPI-T assay with pure GPI-T
Peptide

N-terminus N-terminal seq.

ω

GPI-T Signal sequence

WT CD52

Abz

GQNDTSETSSP

S

ASSNISGGIFLFFVANAIIHLFCFS

1

Abz

GQNDTSETSSP

S

ASSNISGGIFLFFVANAIIHLFCFS

2

Abz

GQKDTSEKSSP

S

ASKN*YSGGIFLFFVANAIIHLFHFS

3

Abz

GQK(Biotin)DTSEKSSP

S

ASKN*YSGGIFLFFVANAIIHLFHFS

Abz; 2-aminobenzoic acid, *Y: 3-nitrotyrosine. Bold residue indicates the site of
biotin attachment. Underlined residues were modified from the native CD52
sequence as described in the text
2.2.2 Preparation of Crude Microsomes Containing GPI-T
Crude microsomes were prepared using the yeast strain YDR331W (YDC1178,
Open Biosystems) which encodes Gpi8 with an appended tandem affinity
purification (TAP) tag {Rigaut, 1999 #47;Puig, 2001 #48;Morissette, 2007 #710}. The
TAP tag is composed of a calmodulin-binding peptide (CBP), a TEV protease
cleavage site, and Protein A, which enables the two-step purification of Gpi8 and
visualization by Western blot. Crude microsomal extracts were prepared based on a
protocol developed by Conzelmann and coworkers (138). Briefly, cells were grown
to mid-log phase and lysed with liquid nitrogen; the cell lysate was centrifuged at
high velocity to obtain the microsomes. Several nonionic detergents were tested to
obtained the best detergent solubilized microsomes as shown in an anti-Protein A
Western blot (Figure 2.5, Dr. Tamara L. Hendrickson). Igepal, triton X-100, and
digitonin successfully solubilized Gpi8. Igepal was chosen as the detergent to
solubilize crude yeast microsomes.
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~ 90 kDa
Figure 2.5 Effect of various non-ionic detergents on solubilizing S.cerevisiae
microsomes carrying TAP tagged Gpi8. TAP-tagged Gpi8 was visualized in an
anti-protein A Western blot. MW: Molecular weight markers Figure courtesy of Dr.
T. Hendrickson.

2.2.3 Initial In Vitro Assay with Crude Yeast Microsomes
Initial assay development efforts were initiated by Dr. R. Morissette (221),
using solubilized, crude yeast microsomes containing GPI-T. A time-dependent
increase in Abz fluorescence was observed when peptide 1 was incubated overnight
in Hepes pH 7.0 buffer, with solubilized microsomes, with and without hydroxylamine
(Figure 2.6, (221)). The observed fluorescence response was higher in the presence
of hydroxylamine (NH2OH) as predicted, suggesting that hydroxylamine is serving as
a GPI anchor mimic as previously reported (105,153). Thus, these results offered
the first indication that this new GPI-T assay was, in fact, measuring GPI-T
transamidation of the substrate peptide. An initial burst in fluorescence response
was observed that was independent of hydroxylamine.
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Figure 2.6 An in vitro GPI-T assay using solubilized microsomes. (A) A timedependent fluorescence response was observed upon incubation of peptide 1 with
crude solubilized yeast microsomes. The observed fluorescence intensity was
higher for the assay with hydroxylamine (NH2OH). (B) The nucleophile dependent
fluorescence response calculated from (A). The nucleophile dependence was
obtained by subtracting the signal without hydroxylamine from the NH2OHcontaining signal. Figure courtesy of Dr. R. Morissette

2.2.4 Extraction and Purification of GPI-T
The enzyme for GPI-T assay was expressed using yeast strain FBY656,
kindly provided by Prof. Conzelmann (138). The FBY656 strain is a GPI8 knockout
strain (MATa ade2-1 ura3-1 leu2-3, 112 trp1-1 his3-11,15lys- GPI8Δ::kanMX2) and
contains plasmid YCplac22-GST-GPI8, encoding for a GST tag on the N-terminus of
Gpi8. Membrane solubilization and purification of the GST-tagged GPI-T complex
was performed essentially as previously reported (138), with only a few
modifications. A cocktail of protease inhibitors was added through the membrane
isolation step; after which, all inhibitors were omitted, except phenylmethylsulfonyl
fluoride (PMSF) to avoid inadvertent inhibition of GPI-T. Protein elution conditions
(from glutathione resin) were also optimized iteratively based on observable activity
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with our FRET assay. Optimal activity was obtained when the enzyme was eluted
once with buffer containing 0.3 % digitonin, 20 mM reduced glutathione (RG), and
PMSF as the only protease inhibitor. Due to poor yield of purified enzyme, the
concentration of GPI-T was not determined. Purified, heterotrimeric GPI-T was
examined by SDS-PAGE with Silver staining (not shown) and by Western blot
(Figure 2.7) with anti GST polyclonal antibodies. These analyses verified the
presence of Gpi8 in this enzyme mixture but the co-purification of Gaa1 and Gpi16
was not confirmed. However, since we used the same yeast strain (FBY656) and
same purification protocol published by conzelmann and co workers, who previously
reported the co-precipitation of yeast Gpi16 and Gaa1 with Gpi8 (138) we proceeded
to assay this enzyme preparation assuming that both Gaa1 and Gpi16 are present in
our enzyme source in addition to GST tagged Gpi8.

(≅72 kDa)

(≅25 kDa)
Figure 2.7 Affinity purification of GST tagged GPI-T. Western blot with anti GST
polyclonal antibody revealed the presence of GST tagged Gpi8. MW - molecular weight
markers Lane 1 - Elution of GST tagged GPI-T from FBY656 strain. Figure courtesy of
Dilani Gamage
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2.2.5 Initial In Vitro Assay with Affinity Purified Solubilized GPI-T
Upon obtaining affinity purified GST-tagged GPI-T, another initial in vitro
assay was performed (Figure 2.8). Peptide 2 was incubated with affinity purified
GPI-T with and without hydroxylamine in the GPI-T assay buffer, pH 7.0. This assay
yielded a significant faster increase in Abz fluorescence compared to the original
assay that used crude yeast microsomes, reducing the necessary assay time from
hours to minutes. Further, no initial burst was observed for no hydroxylamine assay
similar to that of assay with crude microsomes. Instead a slight increase in
fluorescence was observed for no nucleophile assay. This slight increase in
fluorescence response is probably due to the hydrolysis of the amide bond at the ω
site as previously reported (105).
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Figure 2.8. FRET assay with GPI-T. (A) Peptide 2 fluorescence increases over time
in the presence of NH2OH, indicating peptide cleavage and transamidation,
presumably to produce the hydroxamide peptide product. Magenta: 10 mM NH2OH
and 10 µM peptide 2; Maroon: 10 µM peptide 2; Purple: No enzyme control (10 mM
NH2OH and 10 µM peptide 2). (B) Relative rates for the data from panel (A).
Fluorescence intensities were normalized with a GPI-T unit correction factor. The red
dashed line indicates the background fluorescence (no enzyme assay, relative rate =
0.192±0.0216), Data above this line is considered relevant. Data represents the
mean ± SD, n = 3 and P ≤ 0.05 vs. with NH2OH assay (dark grey). Raw data can be
found in Appendix A: Figure A1.

2.2.6 Assay Optimization
As mentioned in section 2.2.3, our first FRET assay was developed by Dr. R.
Morissette using crude yeast microsomes, containing GPI-T (221). With peptide 1,
she

observed

a

significant,

time-dependent

and

hydroxylamine-dependent

fluorescence response suggestive of GPI-T activity. One of the major drawbacks of
this assay was the requirement for a long incubation period (up to 12 hours) to
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obtain a significant response. This requirement affects both enzyme viability and
assay sensitivity. To overcome these problems, we performed another initial assay
with affinity purified GPI-T. This assay also yielded a hydroxylamine-dependent
fluorescence response over a significantly shorter time scale. Therefore we decided
to use affinity purified GPI-T instead of crude microsomes to characterize various
aspects of GPI-T in vitro with this assay.
However, prior to the characterization assays, we set out to further optimize
this GPI-T assay. For optimization, several parameters were assessed, including the
impact of different detergents, pH, reducing agents, nucleophiles, peptide
concentration and enzyme amount. In addition, modifications to the enzyme
purification process and fluorimeter setup were performed to obtain optimized Abz
fluorescence over time. These experiments are described in detail in the following
sections.

2.2.6a The Effect of Different Detergents on GPI-T Activity
Detergents are important to solubilize transmembrane proteins and crude
microsomes and they provide a mechanism to separate membrane-bound proteins
from soluble proteins. Our initial GPI-T assay with affinity-purified GPI-T was
performed using digitonin as the solubilizing detergent. However, the GPI-T assay
performed with crude yeast microsomes used igepal CA-630 (also known as nonidet
P-40) as the detergent (Refer to Figure 2.5) (221).
Hence, we tested igepal CA-630 alone or in combination with digitonin to
determine which detergent yielded optimal results in terms of enzyme yield and
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activity. In contrast to the assay with crude yeast microsomes, peptide 2 precipitated
out of solution in the igepal solubilized assay, leading to a turbidity-induced decrease
in apparent fluorescence. The addition of 0.1% digitonin with igepal CA-630, slightly
lowered the turbidity of the assay buffer, but activity was most robust in 0.1%
digitonin alone (Figure 2.9.). Therefore, we concluded that 0.1% digitonin is the best
for our assay, at least with peptide 2 as the substrate.

Figure 2.9 The effect of igepal and digitonin on GPI-T activity. The negative
relative rates are due to precipitation of peptide 2 over time, which impacts the
observed fluorescence. The red dashed line indicates background fluorescence
(relative rate = 0.192±0.0216). Data above this line was considered relevant to GPI-T
transamidation. Experiments were run in duplicate. Relative rates were calculated
with respect to the 0.1% Digitonin assay (dark gray) and data represents the mean.
without SD. Raw data can be found in Appendix A: Figure A2.
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2.2.6b The Effect of Digitonin Concentration on GPI-T Activity
Next, experiments were conducted to optimize the digitonin concentration in
the assay buffer (Figure 2.10). We tested the impact of different digitonin
concentrations on GPI-T activity. producing a robust fluorescence response in our
GPI-T assay in terms of GPI-T activity. At low (0.05% w/v) and high (0.3% w/v)
concentrations, peptide 2 precipitated from solution, increasing turbidity of the assay
buffer and prohibiting any quantitative assessment of GPI-T activity. The
intermediate digitonin concentrations (0.1% w/v and 0.2% w/v) yielded optimal GPI-T
activity, while alleviating peptide precipitation and turbidity issues. Since 0.1% w/v
digitonin resulted in the highest GPI-T activity, we decided to use 0.1% w/v as the
optimized digitonin concentration for our assay.
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Figure 2.10 Optimization of digitonin concentration. Optimal GPI-T activity was
observed with 0.1% digitonin in assay buffer. The red dashed line indicates
background fluorescence (relative rate = 0.192±0.0216). Data above this line was
considered relevant to GPI-T transamidation. Experiments were run in duplicate.
Relative rates were calculated with respect to the 0.1% Digitonin assay (dark gray)
and data represents the mean without SD. Raw data can be found in Appendix A:
Figure A3.

2.2.6c The Effect of pH on GPI-T Activity
Reaction pH can also be a key factor for enzyme activity. Therefore, we used
different pH buffer systems (varying from pH 6.0 to 9.0) to find the optimized pH for
GPI-T activity (Figure 2.11). A pH of 7.0 yielded the best GPI-T relative rates.
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Figure 2.11 Effect of pH on GPI-T activity. pH 7.0 was chosen as the optimal pH for
the assay buffer. Each experiment was run only once, fluorescence intensities were
normalized with unit correction factor prior to initial rate calculation. Relative rates were
calculated with respect to the optimal rate observed at pH 7.0 (dark gray). The red
dashed line indicates background fluorescence (relative rate = 0.192±0.0216). Data
above this line was considered relevant to GPI-T transamidation. Raw data can be
found in Appendix A: Figure A4.

2.2.6d The Effect of Reducing Agents on GPI-T Activity
The catalytically active subunit of GPI-T, Gpi8 contains an apparent cysteine
histidine catalytic dyad; hence, it is important to maintain a reducing environment in
our in vitro assay. Therefore the impacts of dithiothreitol (DTT, 1 mM) and reduced
glutathione (RG, 20 mM) were analysed (Figure 2.12).
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Figure 2.12 The effect of reducing agents on GPI-T activity. DTT (1 mM) enhances
the GPI-T activity in the prescence of RG (20 mM). Data represents the mean of
duplicate assays. Relative rates were calculated with respect to the assay with both
DTT and RG (dark gray).The red dashed line indicates background fluorescence
(relative rate = 0.192±0.0216). Data above this line was considered relevant to GPI-T
transamidation. Raw data can be found in Appendix A: Figure A5.

RG was assessed because it is present in our assay buffer following
purification of GPI-T by glutathione affinity chromatography. The addition of DTT
improved GPI-T acyivity above that of RG alone. Therefore, we decided to keep both
DTT and RG in our GPI-T assay buffer.
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2.2.6e Effect of Enzyme Amount on Optimal Activity of the GPI-T Assay
Because we can‟t accurately quantify the low levels of GPI-T in our
purification preparations, we decided to optimize GPI-T based on a standard
purification protocol and then to assign a unit definition to the observed
transamidation rate. Similarly, to our preliminary results, the best initial rates for GPIT were obtained when 50 µL of affinity purified GPI-T was used in a 2 mL assay
(Figure 2.13). At lower enzyme concentrations, peptide precipitation overwhelmed
fluorescence detection. Unexpectedly, the fluorescence signal was also ablated at
high GPI-T concentrations (100 µL), perhaps due to turbidity from the enzyme
preparation itself.

2.2.6f Effect of Peptide Substrate Concentration on GPI-T Activity
We also optimized the concentration of peptide 2 for our GPI-T assay (Figure
2.14) and determined that a concentration of 10 µM peptide 2 produced the highest
initial rates. Peptide precipitation was observed with increasing turbidity with 20 µM
of peptide 2.
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Figure 2.13 Optimizing GPI-T assay with varying amount of GPI-T enzyme.
Optimal fluorescence response was observed with 50 µL of GPI-T. Data represents
the mean of duplicate assays. Relative rates were calculated with respect to the
assay with 50 µL of GPI-T (dark gray).The red dashed line indicates background
fluorescence (relative rate = 0.192±0.0216). Data above this line was considered
relevant to GPI-T transamidation. Raw data can be found in Appendix A: Figure A6.
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Figure 2.14 Effect of peptide 2 concentration on GPI-T activity. The assay with 10
µM of peptide 2 results the optimal activity. Data represents the mean of duplicate
assays. Relative rates were calculated with respect to the assay with 10 µM of peptide
2 (dark gray).The red dashed line indicates background fluorescence (relative rate =
0.192±0.0216). Data above this line was considered relevant to GPI-T
transamidation. Raw data can be found in Appendix A: Figure A7.

2.2.6g Effect of Different Nucleophiles on GPI-T Activity
The impact of different nucleophiles was also assessed. Assays discussed to
this point all used 10 mM hydroxylamine as the GPI mimic/nucleophile donor.
Hydrazine (N2H2) and ethanolamine phosphate methyl ester (EPME, see appendix
A8 for the structure) a GPI anchor mimic synthesized by Dr Franklin John (97) were
also tested as assay substrates to determine if either molecule is a better substrate
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than NH2OH (Figure 2.15). Compared to the no nucleophile assay, NH2OH proved to
be the best GPI anchor mimic substrate. Surprisingly, in contrast to previous
literature reports (105), NH2NH2 or based on structural similarity to EtNP group of
GPI anchor, EPME were not a robust substrate to mimic GPI anchor, within the
context of our assay.

Figure 2.15 Effect of different GPI anchor mimics/nucleophiles on GPI-T
activity. GPI-T assay with 10 mM NH2OH results the highest GPI-T activity.
Data represents the experiment run in once. Relative rates were calculated
with respect to the assay with 10 mM of NH2OH (dark gray). The red dashed
line indicates background fluorescence (relative rate = 0.192±0.0216). Data
above this line was considered relevant to GPI-T transamidation. Raw data
can be found in Appendix A: Figure A8.
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2.2.7 Analysis of GPI-T Cleaved Hydroxylamine Attached Peptide Products
As the final step in our GPI-T assay development, we wanted to confirm that
the observed fluorescence response corresponds to GPI-T-mediated transamidation
of peptide 2, while simultaneously confirming that the correct ω site was modified.
To investigate this phenomenon, a biotinylated peptide substrate (peptide 3) was
used. Peptide 3, differ from the peptide 2 only by the addition of a biotin group
attached to the side chain of Lys3 (Table 2.1). The presence of biotin allows for
streptavidin purification of peptide fragments after extended incubation with GPI-T.
We expected that this purification would isolate peptide 3 and any N-terminal peptide
products (e.g. the hydroxylamine modified 12 amino acid peptide, hydroxamate 1,
refer to table 2.2) away from GPI-T and other assay components. Next, the purified
peptide mixture was was separated by high performance liquid chromatography
(HPLC). In Figure 2.16, the HPLC trace for peptide 3 (peak 5 b) is shown in green.
Incubation of this peptide with GPI-T led to a dramatic reduction in the concentration
of peptide 3 (Figure 2.16, blue trace, peak 5a). Furthermore, four new products
(Figure 2.16, blue trace, peaks 1-4) were observed; each of which is a potential
product from the GPI-T reaction.
Peaks 1-4 were collected and analyzed by mass spectrometry. Unfortunately,
this analysis did not reveal the expected product, the hydroxamate 1 (the 12 Nterminal amino acids of peptide 3, with Ser12 modified to a hydroxamate) (Table
2.2). Instead, mass spectroscopic analysis of peak 2 revealed presence of two
products with masses close but not equal to the calculated masses of two GPI-T
cleaved truncated hydroxamates of peptide 3 (refer to Table 2.2). These truncated
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hydroxamates represents hydroxamate 2 with 4 N-terminal amino acids, cleaved
after Asp4 and hydroxamte 3 with 7 N-terminal amino acids, cleaved after Glu7. The
residues Asp4 and Glu7 also represent alternative ω sites of the peptide 3. Efforts to
optimize these mass spectrometric experiments are currently being conducted by
other members of the Hendrickson research group.

Table 2.2 - GPI-T cleaved hydroxylamine attached peptide products
(hydroxamates)
Hydroxamate

Sequence

1

Abz -GQK(Biotin)DTSEKSSPS-NHOH

2

Abz -GQK(Biotin)D-NHOH

3

Abz -GQK(Biotin)DTSE-NHOH

Calculated MW

Observed MW

(M+H)

(M+H)

1611

-

807

809

1124

1122

Abz; 2-aminobenzoic acid, *Y: 3-nitrotyrosine. Bold residue indicates the site of
biotin attachment. Underlined residues were modified from the native CD52 (Table
2.1) as described in the text
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Figure 2.16 HPLC analysis of GPI-T treated peptide products. (A) HPLC trace of
the purrified peptide 3 (green trace). (B) HPLC trace of assay products after
strepatviadin purification (blue trace). Both traces correspond to equal starting
amounts of parent peptide 3. Clevage products on trace B (peaks 1-4) indicates new
assay products were formed. Peaks 5a and 5b represents the parent peptide 3. The
labeled fractions were analyzed by ESI

2.3 DISCUSSION
In this chapter, we described the development and optimization of a high
throughput in vitro assay to kinetically analyze GPI-T. Over three decades of GPI-T
research, many assays have been developed to elucidate various aspects of GPI-T
activity. These methods have remained fairly qualitative. Further, no assay
successfully demonstrated the GPI-T activity in vitro with pure enzyme. However,
with the emerging importance of GPI-T in cancer (9-11), there is an urgent
requirement for a high throughput, quantitative in vitro assay for this enzyme.
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2.3.1 Initial In Vitro Assay with Crude Yeast Microsomes
FRET assay development was initiated by Dr. Rachel Morissette (221). She
demonstrated a significant nucleophile dependent fluorescence response over time
upon incubating a peptide substrate with crude yeast microsomes carrying active
GPI-T. These results offered the first indication that this assay was, in fact,
measuring GPI-T mediate transamidation of the substrate peptide. However, this
assay was associated with some limitations. An initial burst in fluorescence response
was observed that was independent of the hydroxylamine nucleophile. We
hypothesize that this burst is due to trace amounts of endogenous GPI anchor in the
crude microsomes. The assay also required a long incubation time (hours), typical of
most enzyme assays. This will affect both enzyme viability and assay sensitivity. To
overcome these limitations we decided to further develop and optimize this FRET
assay. Our goal was to obtain a robust nucleophile dependent fluorescence
response within a short period time, using a purer form of the enzyme.

2.3.2 Initial In Vitro Assay with Pure GPI-T
The first hurdle to overcome was to find a suitable enzyme source for GPI-T.
We chose to utilize affinity purified GPI-T, based on a purification reported by
Conzelmann and colleagues (138). This procedure did not provide enough enzyme
to assess for concentration, but it did provide GST tagged Gpi8 enriched enzyme
isolated from other microsome components. Assays with affinity purified GPI-T
remained nucleophile-dependent, lacked the initial nucleophile independent activity
observed with crude microsomes, and activity was quantifiable on a minute time
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scale. The significant difference in initial fluorescence response observed for the
assays with and without hydroxylamine is consistent with a GPI-T mediated
transamidation reaction. Unexpectedly, a slight increase in fluorescence response
was also observed for the peptide only control (Figure 2.7.). We do not understand
this phenomenon. Furthermore, over time, the parent peptide substrate precipitated
from the assay buffer in the absence of nucleophile or enzyme, causing a significant
reduction in fluorescence from sample clouding

2.3.3 Optimization of In Vitro FRET Assay with Purified GPI-T
Upon obtaining a significant nucleophile-dependent fluorescence response
over a short time scale, our next hurdle was to optimize the components of the
assay buffer with the aim of further enhancing enzyme activity in our assay.

2.3.3a Digitonin is the Optimized Detergent to Solubilize GPI-T
Detergents form micelles, which loosely mimic biological membranes. These
micelles are essential to extract and solubilize membrane proteins in cell free
systems. The impact of digitonin and igepal on GPI-T activity was assessed, with
digitonin alone providing the strongest activity (Figure 2.9). We used 0.3% w/v
digitonin to purify GPI-T by glutathione affinity purification (Gpi8 was modified with a
GST tag). However, this digitonin concentration induced turbidity under our assay
conditions, presumably due to the limited solubility of digitonin in aqueous solution
and its tendency to precipitate over time at 30 °C (the temperature used for our
FRET assays). Reduction of digitonin to 0.1%-0.2% alleviated this problem (Figure
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2.10.). On the other hand, further reduction in the concentration of digitonin resulted
in peptide substrate precipitation and turbidity. Clearly, there is a „Goldilocks Zone‟
with respect to digitonin concentration: Too little and the peptide precipitates; too
much and the digitonin precipitates. In both cases, turbidity eliminated the ability to
observe GPI-T transamidation of the peptide substrate.

2.3.3b DTT and RG Enhance the GPI-T Activity
Incorporation of reducing agents are necessary for GPI-T assay to prevent
possible cysteine oxidation, particularly in the Gpi8 active site. Reduced glutathione
was a component of our assay buffer, simply because it was used to elute GPI-T
from the glutathione affinity column. Addition of DTT caused a further enhancement
of GPI-T activity, suggesting that insufficient RG remained to maintain a reducing
environment. We did not analyze the impact of DTT alone because of the
requirement for RG during GPI-T purification.

2.3.3c Effect of Enzyme Amount and Peptide Concentration
We also optimized the impact of enzyme (Figure 2.13) and peptide (Figure
2.14) concentration. A standard enzyme concentration was selected (50 mL, see
experimental section for details) for optimal activity and an enzyme unit was defined
to be 3 a.u./min. Similar to our digitonin experiments, peptide solubility limited the
applicability of lower enzyme amounts. Unfortunately, this result highlights some of
the difficulties faced when studying GPI-T. A 5 L cell culture yields only 1 mL of
affinity purified enzyme (in 50%) glycerol. Thus, the number of assays that can be
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conducted with a single preparation is severely restricted. Unexpectedly, the
fluorescence signal was also ablated with higher concentrations of GPI-T, perhaps
due to effects of one or more of the components in the enzyme preparation (e.g.
glycerol, digitonin, etc.). A similar trend was observed with different peptide
concentration. Here again the fluorescence response was relatively low at both low
and high peptide concentrations, indicating an insufficient amount of substrate and
excess precipitation, respectively.

2.3.3d Effect of Different GPI Anchor Mimics
As the final assay optimization step, we tested different GPI anchor mimics as
substrates in our assay. Hydroxylamine and hydrazine were chosen as potential
nucleophile donors due to published evidence that these compounds are suitable
nucleophiles for GPI-T in in vitro translational assays, in the absence of GPI anchor
(105).However, hydroxylamine proved to be the best substrate with minimal activity
with either EPME or hydrazine (Figure 2.15). While at first glance the negative
results with EPME were surprising because this compound‟s similarity to the GPI
anchor, EPME is not as potent a nucleophile as hydroxylamine ( which is activated
by the alpha effect) (224).

Unfortunately, only limited quantities of EPME were

available so this potential substrate was only assayed once.
With these optimization steps, we have developed the first high throughput in
vitro assay to kinetically analyze the catalytic activity of GPI-T. We are now
positioned to characterize aspects of GPI-T that were previously inaccessible. Some
of these efforts will be discussed in detail in chapter 3. In total, these optimization
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experiments highlight the challenges that have limited GPI-T assay development
over the past 20+ years.

2.3.4 Analysis of GPI-T Hydrolyzed Peptide Products
As discussed in section 2.2.4, efforts were made to isolate and mass
spectrometrically analyze peptide products from our GPI-T assay. The aim of this
experiment was to verify that the fluorescence response is due to the GPI
transamidation reaction, producing a hydroxamate peptide. As shown in Figure 2.16,
we observed the formation of new products and the loss of starting peptide , when a
GPI-T assay was analyzed by HPLC. To our surprise, we did not observe the
expected 12 amino acid length hydroxamate 1 by mass spectrometry. Instead, we
observed the formation of truncated hydroxamates 2 and 3 with little variations
between calculated and observed masses (Table 2.2). We believe these truncated
hydroxamates are formed by GPI-T mediated transamidation. Asp4 and Glu7 are
weak alternative ω sites present within the sequence of peptide 3, in addition to the
most probable ω site, Ser 12. May be the presence of biotin tag perturbs the
identification of Ser12 ω site by GPI-T. Despite the fact that we did not observe the
desired product, these results confirm GPI-T activity. Unfortunately, our method of
product isolation was not without weaknesses and requires further optimization. We
purified the peptide products by streptavidin affinity in order to separate these
products from GPI-T and components of our assay buffer. Even with this purification
step, the presence of digitonin complicated mass spectral analysis. To resolve this
matter, alternative purification scenarios will need to be considered. For example,
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the streptavidin and HPLC purification methods can be optimized. Alternatively, the
assay mixture could be extracted with a mixture of chloroform and methanol to
remove the digitonin. Current efforts in the Hendrickson group are focused on
resolving this issue. In the near future, results from these experiments will
presumably confirm that we have successfully reconstituted GPI-T in vitro and have
demonstrated catalytic activity.

2.4 EXPERIMENTAL PROCEDURES
2.4.1 Materials and General Instrumentation
Peptide synthesis reagents were purchased from Advanced ChemTech,
including

N-α-(9-fluorenylmethoxycarbonyl)

tertbutoxycarbonyl(Boc)-2-Abz,

Fmoc-Ser

(Fmoc)-protected
(tBu)-Wang

amino

resin,

acids,
N,

N-

Diisopropylethylamine (DIPEA), N-methyl-2-pyrrolidinone (NMP), O-Benzotriazole-N,
N,

N‟

,N‟-tetramethyl-uronium-hexafluoro-phosphate

(HBTU).

HPLC

grade

acetonitrile (ACN), dichloromethane, acetic anhydride, and EZ-Run pre-stained Rec
protein ladder were purchased from Fisher Bioreagents. Glutathione Sepharose 4B
resin was purchased from GE-Amersham Biosciences. The rabbit anti-GST
polyclonal antibody, and Goat anti Rabbit IgG (Hilyte plus 647 labeled) were
purchased from Genescript and AnaSpec, Inc, respectively. The protease inhibitor
cocktail was purchased from Roche Biosciences. Piperidine, digitonin, reduced
glutathione and all other chemicals were purchased from Sigma-Aldrich and used
without further purification. Centricon centrifugation devices were purchased from
Millipore Corporation.
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Peptides were synthesized both manually and using a Prelude peptide
synthesizer (Protein Technology, Inc.), based on standard solid phase Fmoc
synthesis protocols. The glass peptide synthesis vessel for manual peptide
purification was purchased from ChemGlass Lifesciences. HPLC purification was
performed using a System Gold HPLC (Beckman Coulter, Inc.). Reversed phase
analytical columns were from Agilent Inc., and included a Zorbax SB-C3 (4.6 x 250
mm, 5 μm) used for initial analysis, and a semi-preparative column Zorbax 300SBC3
(21.2 x 250 mm, 7 μm) for bulk purification. A Zorbax SB-C18 analytical column was
used for HPLC purification of GPI-T cleaved assay products. A BioFlo 110 fermentor
(New Brunswick Scientific, Inc.) was used for fermentation growths. Fluorescence
assays were performed on a Varian Cary Eclipse Fluorometer with a Peltier multicell
holder (Agilent Inc.). Mass spectra of peptides were obtained by using either
electrospray mass spectrometry (ESI) or matrix assisted laser desorption/ionization
time of flight mass spectrometry (MALDI-TOF) in Dr. S. Trimpin‟s lab, Department of
Chemistry, Wayne State University.

2.4.2 Buffers and Solutions
Homogenization buffer: 50 mM Tris HCl, pH 7.5 ,1 mM MgCl2 ,1 mM MnCl2.
Cell resuspension buffer: 50 mM Tris HCl, pH 7.5, 1 mM MgCl2, 1 mM MnCl2, 1 mM
dithiothreitol (DTT), 1 mM phenylmethylsulfonylfluoride (PMSF), protease inhibitor
cocktail (pepstatin A, leupeptin, chymostatin, antipain and aprotinin). Membrane
buffer: 50 mM Tris HCl, pH 7.5, 1 mM MgCl2,1 mM MnCl2, 1 mM DTT, 35%
glycerol, 1 mM PMSF, protease inhibitor cocktail. Transmembrane (TM) buffer: 50
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mM Tris HCl, pH 7.4 ,0.2 M mannitol, 0.1 M NaCl, 1 mM MgCl2, 1 mM CaCl2, 1 mM
MnCl, 1 mM DTT, 1 mM PMSF and protease inhibitor cocktail. Glycerol TM (GTM)
buffer: 50 mM Tris HCl, pH 7.4, 0.2 M mannitol, 0.1 M NaCl, 1 mM MgCl2, 1 mM
CaCl2, 1 mM MnCl2, 1 mM DTT, 1 mM PMSF, protease inhibitor cocktail, and 10%
glycerol. Column wash buffer: 50 mM Tris HCl, pH 7.4, 0.2 M mannitol, 0.1 M NaCl,
1 mM MgCl2, 1 mM CaCl2, 1 mM MnCl2, 1 mM DTT, 1 mM PMSF, protease
inhibitor
cocktail, and 0.3% digitonin. Elution buffer: 50 mM Tris HCl, pH 7.4, 0.2 M mannitol,
0.1 M NaCl, 1 mM MgCl2, 1 mM CaCl2, 1 mM MnCl2, 1 mM DTT, 1 mM PMSF,
0.3% digitonin, and 20 mM reduced glutathione. Optimized assay buffer: 50 mM Tris
HCl, 0.2 M mannitol, 0.1 M NaCl, 1 mM MgCl2, 1 mM CaCl2, 1 mM MnCl2, 1 mM
DTT, 1 mM PMSF, 0.1% digitonin, and 20 mM reduced glutathione. On a technical
note, it is important to prepare the digitonin buffer several days before GPI-T
purification to allow sufficient time for maximum solubility. Further, during the buffer
preparation digitonin should solubilize in required amount of water and heat to 95 °C
to enhance the solubility. Fmoc cleavage solution: 20% piperidine, 80% NMP.
Activator solution: 200 mM HBTU, 400 mM DIPEA (2.5 mL). Peptide cleavage
solution: Anisole, thioanisole and trifluoroacetic acid (1: 2: 27 v/v/v).

2.4.3 Yeast Strain and Growth Conditions
Yeast strain FBY656 (MATa ade2-1 ura3-1 leu2-3, 112 trp1-1, his3-11, 15lysGPI8Δ:kanMX2, containing YCplac22-GST-GPI8) was obtained from Professor
Andreas Conzelmann (138). Briefly, a single colony of FBY656, chosen from a –Trp
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SD plate, was used to inoculate 50 mL YPD medium; the culture was incubated
overnight at 37 °C in an incubator with shaking. The overnight culture was used to
inoculate 250 mL YPD medium, which was incubated overnight at 30 °C with
shaking. The 250 mL culture was used as an inoculum for a 5 L fermentation using
the same growth medium at 30 °C with appropriate dissolved oxygen and pH
controls. Preautoclaved antifoam A (100 μL/L) was used to prevent foam formation
during fermentation. The FBY656 cells were collected by centrifugation when they
reached mid-log phase.

2.4.4 Automated Peptide Synthesis
Peptide 2 was synthesized on a Prelude peptide synthesizer using
presubstituted Fmoc-Ser(tBu)-Wang resin (100-200 mesh, 0.10 g, 0.6 mmol/g). The
amino acids were coupled using HBTU chemistry as per the protocols obtained
from the peptide synthesizer manual. Each amino acid was coupled three times in
the presence of activator solution unless otherwise noted. Certain amino acids
required three to four coupling reactions due to the high hydrophobicity of certain
regions of the peptides. Before deprotection of each Fmoc protecting group, the
resin was capped with acetic anhydride. The peptides were cleaved from the resin
by mixing with 1.5 mL peptide cleavage solution and rotating for 2 hours on a wheel
at room temperature. The cleaved peptides were precipitated with cold ether. The
resultant precipitate was lyophilized and purified by reversed phase HPLC. HPLC
fractions were tested by ESI or MALDI-TOF to verify the identity of desired peptide.
The pure peptide fractions were lyophilized and stored dry or as a 1 mM DMSO
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stocks at -20 °C.

2.4.5 Manual Peptide Synthesis
Peptides 2 and 3 were also synthesized manually. Pre-substituted
Fmoc-Ser (tBu)-Wang resin (100-200 mesh, 0.10 g, 0.6 mmol/g) was used for both
peptides and the amino acids were coupled using HBTU chemistry as per the
standard protocols of solid phase Fmoc peptide synthesis. A Kaiser test was
performed after deprotection and after coupling of each amino acid. Based on the
results of the Kaiser test the amino acid coupling time scale was varied. The
peptides were cleaved ,purified and stored as described in section 2.4.4

2.4.6 Extraction and Purification of the GST-tagged GPI-T Complex
2.4.6a Preparation of Microsomal Membranes and Solubilization of Membrane
Proteins
This process was performed as per the protocols of Conzelmann et al.(138).
Briefly, FBY656 cells (from a 5 L culture) were harvested, pelleted, and washed in
homogenization buffer. Next, the cell pellet was lysed with liquid nitrogen and the
resulting homogenate was resuspended in cell resuspension buffer and clarified by
centrifugation at 820g for 8 minutes. The membrane fraction was isolated by
centrifugation at 60,000g for 1 hour. The supernatant was saved for gel analysis and
the pellet was resuspended in the same buffer and centrifuged again for 1 hour at
60,000g. The pellet was resuspended in a small amount of membrane buffer (~1 mL
for cells from a 5 L culture) sufficient to obtain a membrane suspension. The
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membrane suspension was frozen in liquid nitrogen and stored at -80 °C. The frozen
membrane suspension was thawed gently on ice, mixed with TM buffer, and treated
with 0.2 mg/mL DNAse for 45 minutes at 25 °C with shaking. Digitonin was added to
the mixture until the final concentration was 1.5 % w/v; this mixture was agitated at 4
°C for 45 minutes and pelleted at 60,000 g for 1 hour. The supernatant (the
solubilized membrane protein mixture) was diluted to 0.3% digitonin with TM buffer
and immediately used for affinity purification.

2.4.6b Affinity Chromatography Purification of GST- GPI-T Heterotrimeric
Complex
All purification steps were conducted at 4 °C unless otherwise noted.
The solubilized membrane protein mixture was diluted to 10 mL with TM buffer and
mixed with 1 mL glutathione sepharose 4B resin. The mixture was incubated
overnight on a wheel; then the supernatant (unbound fraction) was removed and
the protein-bound resin was washed three times with 10 mL column wash buffer for
15 minutes followed by 1 hour for sedimentation. The supernatants from each wash
were preserved for gel analysis. The bound protein was first eluted (Eluate 1) by
adding 1 mL of elution buffer (TM buffer + 0.3 % digitonin + 20 mM reduced
glutathione) and then eluted a second time (Eluate 2) with another 1 mL of elution
buffer, containing 100 mM reduced glutathione. The resin was incubated with each
elution solution for 30 minutes with gentle agitation, followed by 30 minutes
sedimentation. Each supernatant (eluted protein) was carefully removed and
concentrated using Centricon centrifugation devices (Millipore Corp., Bedford, MA).
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For each 5 L enzyme prep the eluted protein samples were concentrated to 500 μL
and combined with another 500 μL 50 % glycerol before stored at -20 °C.

2.4.6c Detection of GST-Gpi8
Affinity purified GPI-T was loaded onto a 10% polyacrylamide gel for SDS–
PAGE analysis. The gel was stained with silver nitrate to detect the presence of
GST-Gpi8, Gpi16 and Gaa1, as per the manufacturer‟s instructions. The presence of
GST-tagged Gpi8 was also confirmed by Western blotting with anti-GST antibody.
Rabbit anti-GST polyclonal antibody was used as the primary antibody. Goat antiRabbit IgG (Hilyte plus 647 labeled) was used as the secondary antibody. Western
blotting was performed as per the protocols provided by the manufacturer of the
antibodies.

2.4.7 Fluorescence Assay
All peptides used for the assay were prepared as 1 mM DMSO stocks, sterile
filtered, aliquoted in 20 μL fractions, and stored at -20 °C. Assay buffers were
prepared in advance as large-scale stock solutions and stored at 4 °C. For each
assay, the required amount of peptide and buffers were taken out 15 minutes prior to
the experiment and equilibrated at room temperature for 10 minutes and then at 30
°C for 5 minutes. Freshly prepared 1 mM DTT and 1 mM PMSF were added to the
assay buffers, mixed well and filtered with 0.45 μM sterile filters immediately before
each assay. Each peptide was mixed with 1.93 mL assay buffer with or without
nucleophile substrate. Fluorimeter settings were set to the following parameters:
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excitation wavelength: 321.0 nm; emission wavelength: 417.0 nm; excitation slit
width: 10 nm; emission slit width: 5 nm; temperature: 30 °C. Assays were initiated by
the addition of 50 μL of a typical GPI-T enzyme preparation. Assays were mixed
throughout the kinetic run using small magnetic stir bars. Fluorescence emission
was monitored over time at 10-second intervals.

2.4.8 Analysis of GPI-T Cleaved Hydroxylamine Attached Peptide Products.
The fluorescence assay was performed with biotinylated peptide 3 and GPI-T
for 3 hours at 30 °C using the fluorimeter parameters specified in section 2.5.6. For
each assay, 0.05 mg of peptide 3 was incubated with 100 μL GPI-T with 10 mM
hydroxylamine. Twenty assays were performed simultaneously, utilizing a total of 1
mg peptide 3 and 2000 μL GPI-T obtained from 2 enzyme purifications that were
pooled together. Assay samples were frozen at -80 °C immediately after the
incubation period. Once all samples were obtained, the frozen samples were
thawed back to room temperature and mixed with protease inhibitor cocktail.
Meanwhile the streptavidin sepharose resin was washed with assay buffer without
digitonin. The assay samples were pooled and mixed with this resin (1.5 mL bed
volume). The mixture was incubated at room temperature for 1 hour with agitation.
The supernatant was removed and the resin bound peptide was washed with 6 mL
H2O. The resin was resuspended in 2 mL H2O , and incubated at 70 °C for exactly
2 minutes to reversibly broken the biotin-streptavidin interaction (225). The
supernatant, carrying peptide 3 and any biotinylated peptide fragments, was
removed immediately to prevent rebinding to the resin. The samples were
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lyophilized and analyzed by HPLC using a 40-100% ACN/H2O gradient over 41
minutes. The fractions were collected and analyzed by ESI.

2.4.9 Methods to Calculate GPI-T Activity
Each fluorescence assay was run in two or three independent experiments,
each using a different batch of GPI-T to account for variability between preparations.
An arbitrary GPI-T unit of 3 a. u./min (a. u. = arbitrary units) was defined and
fluorescence intensities were normalized with a unit correction factor. The unit
correction factor was calculated separately for each individual enzyme batch . In
order to do so, for every enzyme batch purified, first, a standard assay was
performed with 10 mM NH2OH, 10 μM peptide 2, and 50 μL enzyme. The
fluorescence intensity obtained over the first 5 minutes of this assay was divided by
15 a.u./5 min scale (based on defined GPI-T unit 3 a.u./min) to obtain a unit
correction factor for that particular batch of enzyme. For instance, if an enzyme
batch produced fluorescence intensity of 30 a.u during the first 5 minutes of the
assay, then the unit correction factor for that particular enzyme batch would be 2.
This unit correction factor was used to normalize fluorescence intensity values for
comparison between different enzyme preparations. Next, initial rates were
calculated for the fluorescence data normalized with the unit correction factor. Data
for initial rate determinations was varied from experiment to experiment based on
the linear range of fluorescence change over time (refer to initial rate calculation
data in appendix A). Next, each initial rate value for a particular experiment was
divided by the average initial rate (averaged from triplicate or duplicate assays) of
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the standard assay to obtain relative rates. Standard assay (represented in dark
gray in vertical bar graphs) has a relative rate of ≅ 1 and the other assays were
adjusted accordingly. For example, in Figure A1 (B) of Appendix A, the highest initial
rate was obtained for the assay with NH2OH. The assay was run in triplicate and the
three initial rates (3.01, 3.05 and 2.97 a.u./min) were averaged to obtain a mean
initial rate (3.01 a.u./min). This value was used to divide all the initial rate values
(2.87, 3.06 and 3.15 a.u./min) obtained for assay with NH2OH to obtain relative rate
values (1.00, 1.02 and 1.05). The mean±SD value of the three relative rates
(=0.999±0.00666) corresponding to with NH2OH assay were represented in a
vertical bar graph. For the same data set, the assay without hydroxylamine and no
enzyme gave lower initial rates (1.51, 2.01, and 1.41 a.u./min and 0.702, 0.485 and
0.553 a.u/min respectively). Each initial rate is first divided by the average initial rate
of with NH2OH assay, 3.01 a.u/min, to obtain relative rate values. For no NH2OH
assay relative rates are 0.502, 0.668 and 0.468 and the mean±SD value of three
relative rates was equal to 0.546±0.0619. For no enzyme assay the relative rates
are 0.233, 0.161 and 0.184 and the mean±SD value of three relative rates was
equal to 0.192±0.0216. obtained to obtain relative rates (0.54, 0.60 and 0.48) for no
NH2OH assay. The mean±SD values of with NH2OH, no NH2OH and no enzyme
assays were represented in a vertical bar graph as shown in Figure 2.7. In this way,
assays from different enzyme purifications and using different substrates and
nucleophiles could be directly compared. Background fluorescence was observed
over time in a no enzyme control assay (10 mM NH2OH and 10 μM peptide 2 and
assay buffer).This background fluorescence (mean relative rate = 0.192) is
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represented as a red dashed line in all the plots. The data above this line is
considered significant and relevant to GPI transamidation.

2.4.10 Statistical Analysis
Each independent experimental trial was performed two or three times. The
relative rates were expressed as the mean±SD for n≥3 and as the mean for n=2.
Statistical analysis was performed using a two-way, unpaired t-test with 95%
confidence interval for n≥3. P-Values<0.05 were considered statistically significant.
GraphPad Prism and KaleidaGraph software packages were used to analyze and
plot the data. Vertical column bar graphs, representing mean±SD of the relative
rates were used for assays in triplicate. Vertical column bar graphs and scattered
plots (Appendix A) were used to represent relative rates for the assays done in
duplicate. Scattered plots were used specifically to represent the difference in
individual relative rates from the mean in the absence of p-values and error bars.
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Chapter 3
Enzymatic Characterization of the Catalytic Activity of S. cerevisiae GPI-T
3.1 INTRODUCTION
GPI-T is an important enzyme for eukaryotic organisms. Several in vivo and
in vitro assays have been developed to investigate GPI-T (see chapter 2). The
limitations of these assays prevented detailed kinetic analyses and mainly reported
qualitative

information(111,112,115,119,123-125,131,139,142-146,148,151,158-

161,165,166,208). However, with emerging research on GPI-T, especially in the
medicinal field (9-11,198-200). there is an urgent requirement for a kinetic analysis
of this enzyme and for rapid methods to screen GPI-T inhibitors. Consequently, our
new in vitro assay becomes an indispensable tool to characterize GPI-T. This
chapter describes our efforts towards characterizing GPI-T‟s catalytic activity by
investigating its peptide substrate recognition requirements, species specificity, GPIT inhibitors, and the possibility of cofactor involvement in catalysis.

3.1.1 Recognition of the C-terminal GPI-T Signal Sequence by GPI-T
The C-terminal GPI-T signal sequence contains three key identity elements:
the

ω

site,

the

hydrophilic

spacer

region

and

the

hydrophobic

region

(57,111,112,115,124,125,226). The requirements for these regions were discussed
in detail in Chapter 1 and are briefly summarized in the following sections.
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3.1.1a Sequence Requirements for the ω-Site Region
The ω site amino acid is always a relatively small, hydrophilic amino acid
such as Ser, Gly, Ala, Asp, Cys, Leu and Val.(111,112,114,115) Deletion of this
residue or replacement with a larger amino acid eliminates GPI anchoring (115).
These results confirmed that ω site residue is a key determinant used by GPI-T to
identify appropriate substrate proteins. Amino acid specificity at the ω+1 and ω+2
residues is also important for an effective GPI transamidation reaction. Any amino
acid other than proline is acceptable at the ω+1 site.(119) However, ω+2 site
requirements are more stringent; this site should always contain a small amino acid
such as Gly, Ala and Ser for an effective GPI transamidation.(119,120,227)

3.1.1b Hydrophilic Spacer Region Requirements
The spacer region does not contain a consensus sequence and is composed
of a stretch of mostly hydrophilic amino acids (116,118,121,122). Relative
hydrophilicity and the length of this region are important determinants in the overall
GPI-T signal sequence. Furukawa and coworkers showed that truncation of the eight
amino acid spacer region in bovine 5′-nucleotidase (a GPI anchored protein) to four
amino acids abrogated GPI anchoring (122). However, elongation with alanines
back to 14 amino acids restored GPI anchoring. This spacer region may also have a
role in maintaining the proprotein in a unique conformation for introduction into the
active site of GPI-T (118).
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3.1.1c C-terminal Hydrophobic Region Requirements
The C-terminal GPI-T signal sequence ends with a hydrophobic stretch of
amino acids. Like the hydrophilic spacer, this hydrophobic region does not contain a
consensus sequence but its relative hydrophobicity and length govern GPI
anchoring efficiency of substrate proteins (57,123-125). For instance, compared to
wild type PLAP, which has a 23 amino acid GPI-T signal sequence, PLAP mutants
truncated to a 17 amino acid signal sequence were not GPI anchored and were
translocated to the cytosol. Further, extension of these PLAP mutants with
hydrophobic residues restored GPI anchoring, while extension with hydrophilic
residues did not. Similar results were obtained with S. cerevisiae Gas1p(57) and
human DAF (124). The hydrophobic domain may also contribute to proper
orientation of the ω residue in the GPI-T active site by temporarily anchoring the
substrate protein to the inner leaflet of the ER membrane where GPI-T is localized
(127).

3.1.2 Species Specificity of GPI-T
As described in section 3.1.1, GPI-T substrate proteins contain C-terminal
signal sequences with a pattern of hydrophilic and hydrophobic residues. However,
even within these minimal sequence requirements, GPI-T exerts apparent species
specificity (128-131). Presumably, structural variations in the GPI-T active site
and/or the GPI-T signal sequences between different organisms lead to speciesspecific selection of substrate proteins (128,130,131). For example, the gene
encoding human growth hormone (hGH), a soluble protein, was modified to append
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three different GPI-T signal sequences onto its C-terminus; the anchoring efficiency
of each of these recombinant proteins was quantified. The signal sequences came
from T. brucei VSG, human DAF, and P. berghei circumsporozoite protein (CS).
Only the human DAF sequence imparted GPI anchoring in mammalian COS cells.
Sequence analyses suggested that the parasitic ω region is incompatible with
mammalian GPI-T machinery due to structural variations within the ω residuebinding pocket of mammalian GPI-T (128). GPI-T species specificity was also
probed by the Hendrickson lab, by appending two human and one yeast GPI-T
signal sequences onto the C-terminus of the yeast secretory protein invertase (INV)
(131). The human sequences were derived from the campath-1 antigen (CA25) and
the urokinase-type plasminogen-activated receptor (UP30), and the fungal sequence
was from the S. cerevisiae GPI-AP, yapsin 2 (Y21). They demonstrated that the
yeast sequence produced the highest levels of GPI-anchored INV on the cell surface
of S. cerevisiae. A series of chimeric signal sequences, combining portions of the
Y21 and the CA25 sequences, pinpointed discrimination to a six-residue portion of
the GPI-T signal sequence; this peptide fell within the hydrophobic region of the
signal sequence.

3.1.3 Is GPI-T Activity Regulated in vivo?
GPI-T is associated with human diseases like cancer (9-11,198). In order to
develop chemotherapeutics, it is important to identify ways to control GPI-T activity,
either via inhibitors or at the level of expression. Unfortunately, investigations
focused on regulating GPI-T activity/expression have been limited. One limit to such
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research is a lack of background information on GPI-T catalysis from a quantitative,
mechanistic viewpoint. The structurally complicated nature of GPI-T and absence of
high throughput quantitative assays with pure solubilize GPI-T account for this
situation.
The only mechanistic information available for GPI-T stems from Gpi8‟s
sequence and putative structural similarity to cysteine proteases (156,157),
especially to caspases (143,151,152). The Gpi8 subunit contains a cysteine/histidine
catalytic dyad similar to that of cysteine proteases (148,151,158). Consistently,
sulfhydryl alkylating agents like iodoacetamide inhibit GPI-T (150,153).
The impact of nucleotide cofactors on GPI-T activity was also investigated.
The results were contradictory (135,136,228) as some report that nucleotide
cofactors enhance GPI-T activity while others report no impact. However, this
question requires further investigation with an assay like ours, which uses affinitypurified GPI-T (135,136,228). One of the goals of the research described in this
chapter was to apply our FRET assay for GPI-T (introduced in chapter 2) to answer
these questions.

3.2 RESULTS
3.2.1 Design and Synthesis of Peptide Substrates
In order to analyze the catalytic activity of purified GPI-T, small propeptides
(Table 3.1 and Table 3.2) were synthesized based on the human campath–1 (CD52)
antigen and yeast aspartyl protease (Yapsin 2). As detailed in section 2.2.1 the
propeptide sequence of wild type CD52 was modified to peptide 2; this peptide was
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used to develop our GPI-T assay. Peptides 4 and 5 are based on peptide 2 with
single ω site mutations. These peptides were designed to demonstrate that our
assay shows the same ω site requirements as more established GPI-T assays.
Since GPI-T only accepts small amino acid residues at the ω site, we hypothesized
that peptide 4 would be, at best, a weak substrate for GPI-T while peptide 5 would
not be a substrate. A series of peptides (6-10) were constructed to determine the
sensitivity of our assay to C-terminal truncations. Dr. Rachel Morissette
(Hendrickson lab alumna) synthesized peptides 2, and 4-10 (Table 3.1).

Table 3.1 Peptide substrates to study GPI-T signal sequence variations
Peptide

N-

N-terminal seq.

ω GPI-T Signal sequence

GQNDTSETSSP

S

ASSNISGGIFLFFVANAIIHLFCFS

terminus
WT CD52
2

Abz

GQKDTSEKSSP

S

ASKN*YSGGIFLFFVANAIIHLFHFS

4

Abz

GQKDTSEKSSP

D

ASKN*YSGGIFLFFVANAIIHLFHFS

5

Abz

GQKDTSEKSSP

R

ASKN*YSGGIFLFFVANAIIHLFHFS

6

Abz

GQKDTSEKSSP

S

ASKN*YSGGIFLFFVANAIIHL

7

Abz

GQKDTSEKSSP

S

ASKN*YSGGIFLFFVANA

8

Abz

GQKDTSEKSSP

S

ASKN*YSGGIFLFF

9

Abz

GQKDTSEKSSP

S

ASKN*YSGGIFL

10

Abz

GQKDTSEKSSP

S

ASKN*YS

Abz; 2 - aminobenzoic acid, *Y: 3-nitrotyrosine. Underlined residues were modified
from the native, wild-type sequence for CD52, as described in Chapter 2.
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Yapsin 2 was selected to analyze the species specificity of GPI-T, in
comparison to peptide 2 (which is based on the human CD52). Among different S.
cerevisiae GPI anchored proteins (117,229), we chose Yapsin 2 due to the predicted
synthetic accessibility/solubility of its C-terminal GPI-T signal sequence. The native
signal sequence also has useful positions to introduce the Abz fluorophore (on the
side chain of Lys25) and the 3-nitrotyrosine quencher (in place of Phe14). The Nterminal threonine was acetylated to avoid attachment of an extra Abz group. Dilani
Gamage (current Hendrickson lab member) synthesized peptide 11 based on the
amino acid sequence of WT Yapsin 2 (Table 3.2).

Table 3.2. Peptide substrate based on a fungal substrate for GPI-T
Peptide

N-

N-terminal

terminus

seq.

WT

ω

GPI-T Signal sequence

TRKE

N

GGHNLNPPFFARFITAIFHHI

TRK(Abz)E

N

GGHNLNPP*YFARFITAIFHHI

Yapsin 2
11

Ac

Abz; 2 - aminobenzoic acid, *Y: 3-nitrotyrosine. Underlined residues were
modified from the wild-type sequence as described in the text
3.2.2 Extraction and Purification of GPI-T
GPI-T was purified as described in section 2.2.3 of Chapter 2.
3.2.3 The Effect of ω Site Identity on Substrate Recognition by GPI-T
Amino acid specificity at the ω site of the GPI-T signal sequence has been
analyzed

qualitatively

using

both

in

cell

and

cell

free

assays

(111,112,114,115,120,227). However, none of these experiments were quantitative
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and relied on endogenous or crude microsomes as the source of GPI-T. We decided
to quantitatively analyze the impact of amino acid specificity at the ω site using our
new GPI-T assay (Figure 3.1). Three CD52 peptides with variations at the ω site
were tested as substrates for GPI-T (Table 3.1). Peptide 2 contains the wild-type
Ser12 at the ω site, while peptides 4 and 5 contain Asp12 and Arg12, respectively.
Consistent with previous results (111,112,114,115) and bioinformatic analyses
(5,6,230), peptide 2 was the best substrate for GPI-T. These results offer further
evidence that our assay is monitoring GPI-T directly.

Figure 3.1. Effect of the identity of the ω site amino acid on substrate
recognition by GPI-T. Peptide 2, with serine at the ω site, yields the highest
initial rate of transamidation. The red dashed line indicates background
fluorescence (relative rate = 0.192±0.02). Data above this line was considered
relevant to GPI-T transamidation. Data represent the mean ± SD, n = 3 and
P<0.05 compared to peptide 2 (ω = serine, dark gray). For raw assay data,
see Appendix B, Figure B1.
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3.2.4 The Importance of the Length of the GPI-T Signal Sequence on Substrate
Recognition
The overall hydrophilic and hydrophobic profile as well as the length
of the GPI-T signal sequence are key parameters that determine transamidation
efficiency.(57,111,112,115,124,125,226) Lack of these elements converts a
substrate protein into a non-substrate (231). Therefore, in accordance with this
information, we used our in vitro assay to analyze the impact of signal sequence
length on substrate activity. A series of truncated analogs of peptide 2 (peptides 6 10, Table 3.1) were used for this purpose. None of the shortened peptides were
robust substrates for GPI-T, when compared to full-length peptide 2 (Figure 3.2). In
fact, the loss in GPI-T activity correlated with the length of each truncation; the
longest peptide was the best substrate and the shortest two peptides were not
substrates at all (within the sensitivity limits of our assay).
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Figure 3.2 Effect of the length of the C-terminal GPI-T signal sequence on
substrate recognition by GPI-T. Peptide 2 the wild-type GPI-T signal sequence
yielded the highest initial rate of transamidation. GPI anchoring activity diminished
as the length of the signal sequence was shortened. The red dashed line
indicates background fluorescence (relative rate = 0.192±0.0216). Data above
this line was considered relevant to GPI-T transamidation. Data represent the
mean ± SD, n = 3 and P≤0.05 compared to peptide 2 (dark gray).

3.2.5 Species Specific Substrate Selectivity of GPI-T
GPI-T appears to have different affinities towards peptide substrates from
different species (128,130,131). To investigate this phenomenon further, we used
our in vitro FRET assay to examine the species-specific substrate specificity of GPIT with two peptide substrates. Our assay development has been based on a human
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peptide substrate for GPI-T, peptide 2; but our GPI-T was purified from S.
cerevisiae. We hypothesized that a fungal peptide substrate would be a stronger
substrate for the fungal GPI-T. We chose to test a yeast peptide substrate (peptide
11) based on the C-terminus of the aspartyl protease Yapsin 2 (Table 3.2) because
of synthetic accessibility and the fact that this signal sequence was a robust
substrate for GPI-T when tested with our in vivo invertase assay (131). Activity was
compared to our standard CD52 substrate peptide 2 (Table 3.1). Each peptide was
separately assayed with pure GPI-T. Since both Yapsin 2 and GPI-T are from S.
cerevisiae, we expected peptide 11 be the stronger substrate. However, the
fluorescence response produced with peptide 11 was negligible, even at higher
peptide concentrations (Figure 3.3.). Efforts to optimize assay conditions for this
substrate were ineffective (not shown).
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Figure 3.3 Species specific substrates and GPI-T. S. cerevisiae GPI-T was
incubated with different concentrations of peptide 11 versus peptide 2 in the
presence of 10 mM NH2OH and S. cerevisiae GPI-T. Peptide 11 was not a
substrate under the assay conditions tested. The red dashed line indicates
background fluorescence (relative rate = 0.192±0.0216). Data above this line
was considered relevant to GPI-T transamidation. Data represents the mean
of experiments run in duplicate. See Appendix B, Figure B3 for raw data.
3.2.6 Effect of Transition Metal Ion Cofactors on the Catalytic Activity of GPI-T
To our knowledge, the possibility that GPI-T requires a metal cofactor has
never been evaluated. Given that some caspases bind metal ions (232-240), we
hypothesized GPI-T might also require a transition metal for activity or regulation. To
test this hypothesis, we compared GPI-T activity in the presence of various transition
metals (Figure 3.4.).
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Figure 3.4 Effect of different transition metals on GPI-T activity. GPI-T
activity was measured with peptide 2 and 10 mM NH2OH in the presence of
different metal ions, each at 1 mM concentrations, and GPI-T. EDTA (1 mM)
was used in a control assay. The red dashed line indicates background
fluorescence (relative rate = 0.192±0.0216). Data above this line was
considered relevant to GPI-T transamidation. Data represent the mean ± SD,
n = 3 and P≤ 0.05 compared to the assay with 1 mM Mn2+ as the transition
metal (dark gray). ns: not significant. See Appendix B, Figure B4 for raw data.
The presence of Mn2+ and Zn2+ enhanced GPI-T activity, compared to the
EDTA control; each of the three other metals tested inhibited GPI-T activity. These
results suggest that the catalytic activity of GPI-T is metal-dependent. Surprisingly,
however, a combination of Mn2+ and Zn2+ ablated enzyme activity, a result that
requires further analysis before precise conclusions can be made.
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3.2.7 The Effect of Leupeptin, a Cysteine Protease Inhibitor, on GPI-T Activity

Figure 3.5 Effect of Leupeptin, a cysteine protease inhibitor, on GPI-T
activity. GPI-T activity was measured with peptide 2 and 10 mM NH2OH in the
presence of different protease inhibitors, each at 1 mM concentrations. Presence
of 1 mM leupeptin completely abolish the GPI-T catalytic activity. The red dashed
line indicates background fluorescence (relative rate = 0.192±0.0216). Data
above this line was considered relevant to GPI-T transamidation. Data represent
the mean ± SD, n = 3 and P≤0.05 compared to assay with 1 mM PMSF as the
protease inhibitor (dark gray). See Appendix B, Figure B5 for raw data.
As mentioned above, Gpi8, the active site subunit of GPI-T, has sequence
homology to caspases and other cysteine proteases (152,156,157). Thus, we
hypothesized that cysteine protease inhibitors might inhibit the active site of Gpi8.
We confirmed this hypothesis by testing the impact of leupeptin, a cysteine protease
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inhibitor, on GPI-T activity (Figure 3.5.). As expected, leupeptin inhibits GPI-T
activity.

3.2.8 Effect of Nucleotides on Catalytic Activity of GPI-T
The impact of ATP and GTP on GPI anchoring has been examined and
reported with contradictory results (135,136,228). However, these assays were
performed in an in vitro translation system with crude GPI-T. Thus, we reassessed
the impact of ATP and GTP using our new in vitro assay (Figure 3.6.). The
fluorescence response for the control assay (without either NTP) was significantly
higher than those with either ATP or GTP (Figure 3.6a). The ATP assay showed an
initial rate that was similar to the control assay; however this assay plateaued at a
significantly lower level, indicating that less peptide substrate was processed. The
relative rate data in Figure 3.6b is based only on the initial rate and does not take the
relative plateau levels into account (Shown in Figure 3.6a). In total, these data
demonstrate that neither GTP nor ATP have any role in enhancing GPI-T activity;
however, they may play some sort of regulatory role as both nucleotides diminished
overall transamidation activity.
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Figure 3.6 Effect of nucleotides on the catalytic activity of GPI-T. GTP
and ATP did not enhance GPI-T activity with peptide 2 as the substrate. (A)
GPI-T activity in terms of fluorescence response. Activity was measured with
10 µM peptide 2 and 10 mM NH2OH with different nucleotides, each at 10 mM
concentrations, and GPI-T. A no NTP assay was performed as a control.
Magenta: no NTP; Purple: 10 mM ATP; Maroon: 10 mM GTP. Error bars
indicate the standard deviation (SD, n=3). (B) Relative rates were calculated
from the initial rate data in A. The red dashed line indicates background
fluorescence (relative rate = 0.192 ± 0.021). Data above this line was
considered relevant to GPI-T transamidation. Data represent the mean ± SD,
n = 3 and P ≤0.05 compared to assay with no NTP (dark gray).
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3.3 DISCUSSION
The lack of quantitative tools and the complexity of GPI-T has limited the type
of studies that could be conducted to better understand this enzyme. Especially,
investigations on the catalytic activity of GPI-T with a more quantitative, mechanistic
approach have been missing. However, our in vitro assay for GPI-T, described in
Chapter 2, offers a new approach to look at GPI-T. In this chapter we describe the
use of this assay to investigate certain aspects of GPI-T catalysis, including peptide
substrate recognition, species specificity and ways to regulate GPI-T catalytic
activity.

3.3.1 Our in vitro GPI-T Assay Distinguishes Between Different ω site
Residues
For our first efforts to characterize GPI-T with our assay, we decided to
confirm previous observations made with GPI-T in vivo or in crude in vitro translation
systems. As detailed in Chapter 1 and section 3.1.1a, the ω amino acid should be a
relatively small amino acid (e.g. Ser, Gly, Ala, Asp, Asn and Cys) (111,112,114,115).
We designed three peptide substrates for this experiment with variations at the ω
site (Ser12, Asp12, and Arg12). As expected, Ser12 was the strongest ω site,
followed by Asp12, and then Arg12 (see Figure 3.1)..Our results were consistent
with previous findings as the highest GPI-T activity was observed with the Ser12 ω
site. GPI anchoring was lower with Asp12 and nearly eliminated with Arg12. These
results provide further support that our new assay is specific for GPI-T activity, rather
than for any non-specific protease contaminant.
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3.3.2 Length of the GPI-T Signal Sequence is Important for Peptide Substrate
Recognition by GPI-T
As described in Chapter 1 and section 3.1.1c above, the hydrophobicity
profile and the length of the GPI-T signal sequence are critical parameters for GPI-T
substrate recognition (57,111,112,115,124,125,226,231). We tested the length of the
C-terminal GPI-T signal sequence using our in vitro assay as a continuation of our
assay validation process and to investigate GPI-T catalytic activity further. A series
of C-terminally truncated peptides (peptide 6-10, Table 3.1) were tested as
substrates for GPI-T. Transamidation activity was completely abolished for peptides
lacking most of the hydrophobic region of the GPI-T signal sequence. In fact, only
peptide 6, the peptide with the shortest truncation, showed any substrate activity
when assayed with GPI-T, compared to that of peptide 2. Overall, these results
confirmed the contributions of the key identity elements, ω region and hydrophobic
region, for GPI-T recognition of substrate peptides.
In 2007, an in vivo GPI-T assay developed by the Hendrickson group
revealed that the replacement of the CD52 (Table 3.1) sequence FVANAI with
Yapsin 2 (Table 3.2) sequence ARFIT enhanced CD52 transamidation (131). For the
moment, we have not synthesized peptides to demonstrate the impact of this
sequence perturbation in vitro. We believe that such a replacement will further
enhance the GPI-T activity of our model peptide substrate.
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3.3.3 Species-Specific Substrate Selectivity of GPI-T
GPI-T appears to exert different affinities towards peptide substrates from
different species (128,130). To investigate this phenomenon further, we used our in
vitro assay to compare two GPI-T substrates from different species. Transamidation
of the yeast peptide substrate based on Yapsin 2 (peptide 11,Table 3.2) was
compared to that of our standard peptide substrate based on the human CD52
(peptide 2). We expected to observe optimal activity with the yeast peptide
substrate, peptide 11, because our assay uses the homologous yeast GPI-T.
However, the fluorescence response produced with 11 was negligible even at higher
concentrations (Figure 3.3), despite efforts to optimize assay conditions. This poor
substrate behavior may be due to the shorter N-terminal region upstream of the ω
site in peptide 11. Peptide 2 contains eleven residues N-terminal to the ω site; this
sequence reflects the entire CD52 wild-type sequence, following ER processing of
the N-terminal signal peptide. In contrast, peptide 11 only contains four amino acids
N-terminal to the ω-site. Further, the peptide 11 sequence only represent a short
fragment of the full-length Yapsin 2 propeptide which is 384 amino acids long. In the
future, a longer Yapsin 2 peptide substrate, with an extended C-terminal GPI-T
signal sequence, needs to be tested.

3.3.4 External Modulators of GPI-T Activity
Due to the highly complicated nature of GPI-T and lack of high throughput
assays, we still do not have a clear picture of GPI-T structure or catalytic activity. For
the first time in GPI-T history, we have a high throughput in vitro assay that uses
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pure, solubilized GPI-T. Further, we recognize the similarities between Gpi8, the
catalytically active subunit of GPI-T, with that of cysteine proteases. As discussed in
Chapter 1, Gpi8 demonstrates 25%-28% sequence homology to the C13 family of
cysteine proteases, with weak sequence similarity at the active site of several
caspases (138,151). Mn2+ binds to and enhances the activity of certain caspases
(233,234,241). However, the impact of Zn2+ on caspase activity is less clear. Zn2+
allosterically inhibits some caspases (236-238), while activating others (242-244).
Cu2+ and Fe2+ can also inhibit caspase activity (239,240). It has also been reported
that low concentrations of Zn2+ (10 - 50 µM) diminished the Mn2+ mediated induction
of caspase 3 activity (243). Moreover, the Hendrickson group recently demonstrated
that the soluble domain of S. cerevisiae Gpi8 has a caspase-like domain and
undergoes homodimerization similar to that of caspases (152). We hypothesized
that the similarities between GPI-T and caspases might include a requirement for a
cofactor for activity.

3.3.4a Transition Metal Ion Cofactors Regulate the Catalytic Activity of GPI-T
We analyzed GPI-T activity in the presence of various transition metal ions as
described in section 3.2.6. Our results demonstrated that Mn2+ and Zn2+ ions
independently enhance the catalytic activity of GPI-T, whereas the combination of
these two cations is disruptive to activity. Cu2+ and Fe2+ each reduced GPI-T activity,
compared to that of EDTA control. Unfortunately, due to lack of structural insight into
GPI-T, a direct explanation of these results is beyond our ability at the present time.
Hence, we depend on indirect information (e.g. with respect to caspases) to

99
hypothesize how these metals might work with GPI-T. In fact, even speculating as to
which subunit mind bind a metal cofactor is beyond our current understanding.

3.3.4b Leupeptin Inactivates GPI-T
Since Gpi8 has 25-28% sequence similarity to cysteine proteases, we
investigated the impact of the cysteine protease inhibitor, leupeptin, on GPI-T
activity. Indeed, Leupeptin inhibited GPI-T, presumably by modification of the
nucleophilic cysteine in the active site. This observation is the first demonstration of
direct inhibition of GPI-T in vitro (to our knowledge). GPI-T activity is not inhibited by
phenylmethylsulfonyl fluoride (PMSF), a serine protease inhibitor, or by EDTA
(ethylenediaminetetraacetic acid), a metalloprotease inhibitor. Overall, these results
continue to strengthen the comparison between GPI-T and caspases.

3.3.4c ATP and GTP Diminish GPI-T Activity
The importance of nucleotide cofactors on GPI anchoring has been studied
previously. In cell free systems, the processing of prominiPLAP to miniPLAP was
enhanced when either ATP or GTP as added (136). It was suggested that ATP
might enhance the proper folding of proprotein substrates, while GTP might facilitate
translocation of the folded proprotein to the active site of GPI-T (136,228). However,
in another cell free assay, in which synthetic GPI anchors were transferred to cell
membranes carrying VSG, GPI addition was not enhanced by either ATP or GTP
(135). Due to these contradictory reports, we reassessed the impact of ATP and
GTP on GPI transamidation in vitro.
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The initial rate of transamidation of peptide 2 was highest in the absence of
NTPs. However, there are significant experimental differences between our assay
conditions and those published in the literature (136). Among them, the use of crude
soluble microsomes by others (136), versus affinity purified enzyme (this work) and
the use of small proteins such as preprominiPLAP (136), compared to the full length
CD52 peptide 2 (this work) are potentially significant. For RM assays, the possibility
that other cellular components are responsible for NTP dependence cannot be ruled
out. These differences may account for the observed contradictions. However, our
results demonstrate that neither GTP nor ATP activates GPI-T.

3.3.5 Conclusions
In this work, we utilized our in vitro assay to characterize several aspects
relevant to the catalytic activity of GPI-T. Our results demonstrate that this assay is
an indispensable tool to investigate GPI-T from a quantitative viewpoint that was
previously inaccessible. Further, this new assay opens up a plethora of experiments
for future research on GPI-T. For instance, even though the Gpi8 subunit catalyzes
the transamidation reaction, this subunit is not active in the absence of other GPI-T
subunits (152). We are now poised to assess the impact of each individual subunit
on Gpi8 activity in order to identify which subunit(s) is necessary to activate Gpi8 for
transamidation. Results from such experiments will solve three decades of
discussions about which subunits constitute the catalytically competent GPI-T
complex. For instance in yeast, GPI-T is divided in to a core heterotrimer, which
likely dimerizes into a heterohexamer (138,140). In humans, GPI-T can be purified
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as a heteropentamer (141,165), presumably leading to two copies of all five subunits
(for a total of 10) in the fully formed GPI-T complex. The assay described herein will
certainly contribute to elucidating the size of the core GPI-T complex.

3.4 EXPERIMENTAL PROCEDURES
3.4.1 Materials and General Instrumentation
Refer to Chapter 2 Section 2.4.1

3.4.2 Buffers and Solutions
Refer to Chapter 2 Section 2.4.2

3.4.3 Yeast Strain and Growth Conditions
Refer to Chapter 2 Section 2.4.3

3.4.4 Automated Peptide Synthesis
Peptides 2, and 4-10 were synthesized as detailed in the Ph.D. thesis of Dr.
Rachel Morissette using standard solid-phase Fmoc synthesis protocols and presubstituted Wang resins (221). Peptide 11 (synthesized by Dilani Gamage) was
synthesized on a Prelude peptide synthesizer using pre-substituted Fmoc-Ile-Wang
resin (100-200 mesh, 0.10 g, 0.6 mmol/g). The amino acids were coupled using
HBTU chemistry using standard Prelude peptide synthesizer protocols. Each amino
acid was coupled three times in the presence of activator solution unless otherwise
noted. Certain amino acids required three to four coupling reactions due to the high
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hydrophobicity of certain regions of the peptides. The resin was coupled with acetic
anhydride before Fmoc deprotection. The peptides were cleaved from the resin by
mixing with 1.5 mL peptide cleavage solution and rotating for 2 hours on a wheel at
room temperature. The cleaved peptides were precipitated with cold ether. The
resultant precipitate was lyophilized and purified by reversed phase HPLC. The
HPLC fractions were tested by ESI or MALDI-TOF to verify the identity of desired
peptide. The pure peptide fractions were lyophilized and stored dry or as a 1 mM
DMSO stock at -20 °C.

3.4.5 Manual Peptide Synthesis
Peptide 2 was also synthesized manually, using pre-substituted FmocSer(tBu)-Wang resin (100-200 mesh, 0.10 g, 0.6 mmol/g) and HBTU chemistry as
detailed in section 2.4.5 of Chapter 2.

3.4.6 Extraction and Purification of the GST-tagged GPI-T Heterotrimeric
Complex
Preparation of microsomal membranes, solubilization of membrane proteins
and affinity purification of GST tagged GPI-T were performed as described in section
2.4.5 of Chapter 2.
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3.4.7 Fluorescence Assay
For each assay detailed in section 3.2, fluorescence response was obtained
using a Varian Cary Eclipse Fluorometer with a Peltier multicell holder (Agilent Inc.)
as described in section 2.4.6 of Chapter 2.

3.4.8 Methods to Calculate GPI-T Activity
Each fluorescence assay was run in triplicate, unless otherwise noted. GPI-T
activity was calculated as described in section 2.5.7 of Chapter 2.

3.4.9 Statistical Analyses
Each experiment was performed three times unless otherwise noted. The
relative rates were expressed as the mean ± standard deviation for n ≥ 3. Statistical
analysis was performed using a two-way, unpaired t-test with 95% confidence
interval for n ≥ 3. P-values < 0.05 were considered statistically significant. GraphPad
Prism and KaleidaGraph software packages were used to analyze and plot the data.
Vertical bar graphs representing mean ± SD were used to represent relative rates.
Scattered plots were also used to represent relative rates for assays run in duplicate.

3.5 ACKNOWLEDGEMENT
Thanks are extended to Dr. Rachel Morissette for peptides 2-10 and Dilani
Gamage for peptide 11.
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APPENDIX A

Figure A1. Initial fluorescence assay with GPI-T. (A) Summary of effects from
enzyme and variations of nucleophile dependence on new GPI-T assay based on
fluorescence response. For all assays, fluorescence intensity was normalized using the
GPI-T unit definition. See text for details Magenta: 10 mM NH2OH + 50 µL GPI-T;
Maroon: 50 µL GPI-T; Purple: 10 mM NH2OH + no GPI-T. Error bars indicate the
standard deviation (n=3). Initial rates of transamidation for the assays with (B) 10 mM
NH2OH (C) no NH2OH and (D) no enzyme assay. Refer to table A1 for experimental
conditions.
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Figure A2. Effect of various non-ionic detergents on GPI-T activity. (A)
Summary of effect of non-ionic detergents on GPI-T activity based on
fluorescence response. For all assays, fluorescence intensity was normalized
using the GPI-T unit definition. See text for details Magenta: 0.1 % Digitonin;
Maroon: 24 mM Igepal + 0.1 % Digitonin; Purple: 24 mM Igepal. n = 2 Initial
rates of transamidation for assay with (B) 0.1% Digitonin.(C) 0.1 % Digitonin
and 24 mM Igepal (D) 24 mM Igepal. (E) Effect of various non-ionic detergents
on GPI-T activity based on relative rates. Relative rates were calculated with
respect to 0.1% Digitonin assay (■).Refer to table A1 for experimental
conditions.
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Figure A3. Effect of Digitonin concentration on GPI-T activity.(A) Summary of
effect of variation in digitonin concentration on GPI-T activity based on fluorescence
response. For all assays, fluorescence intensity was normalized using the GPI-T unit
definition. See text for details. n = 2 Initial rates of transamidation for assay with (B)
0.05% Digitonin (C) 1% Digitonin (D) 2% Digitonin and (E) 0.3% Digitonin (E) Effect of
Digitonin concentration on GPI-T activity based on Relative rates. Relative rates were
calculated with respect to 0.1 % Digitonin assay (■). Refer to table A1 for
experimental conditions.
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Figure A4. Effect of pH on GPI-T activity. (A) Summary of effect of variation in assay
buffer pH on GPI-T activity based on fluorescence response. For all assays,
fluorescence intensity was normalized using the GPI-T unit definition. See text for
details. n = 1 (B) Initial rates of transamidation for assays with different pH conditions.
All assays were performed with 10 mM NH2OH, 10 µM peptide 2 and 50 µL GPI-T with
varion in pH. Refer to table A1 for experimental conditions.
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Figure A5. Effect of reducing agents on GPI-T activity. (A) Summary of effect of
variation in reducing agents on assay buffer on GPI-T activity based on fluorescence
response. For all assays, fluorescence intensity was normalized using the GPI-T unit
definition. See text for details. n = 2 Initial rates of transamidation for assay with (B) 1
mM DTT and 20 mM RG and (C) 20 mM RG (D) Effect of agents on GPI-T activity
based on relative rates. Relative rates were calculated with respect to assay with 1 mM
DTT and 20 mM RG (■).Refer to table A1 for experimental conditions.
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Figure A6. Optimizing GPI-T assay with amount of GPI-T enzyme. (A) Summary
of effect of variation in enzyme amount on GPI-T activity based on fluorescence
response. For all assays, fluorescence intensity was normalized using the GPI-T
unit definition. See text for details. n = 2 Initial rates of transamidation for assays
with (B) 1 µL GPI-T (C) 5 µL GPI-T (D) 50 µL GPI-T and (E) 100 µL GPI-T. (F)
Effect of enzyme amount on GPI-T activity based on relative rates. Relative rates
were calculated with respect to assay with 50 µL of GPI-T(■).Refer to table A1 for
experimental conditions.
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Figure A7. Effect of peptide 2 concentration on GPI-T activity (A) Summary of
effect of variation in peptide 2 concentration on GPI-T activity based on fluorescence
response. For all assays, fluorescence intensity was normalized using the GPI-T unit
definition. See text for details. n = 2 Initial rates of transamidation for assays with (B)
5 µM peptide 2 (C) 10 µM peptide 2 and (D) 20 µM GPI-T (E) Effect of peptide 2
concentration on GPI-T activity based on relative rates. Relative rates were calculated
with respect to assay with 10 µM of peptide 2 (■).Refer to table A1 for experimental
conditions.
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Figure A8. Effect of different nucleophiles on GPI-T activity (A) Summary of effect
of different nucleophiles on GPI-T activity based on fluorescence response. For all
assays, fluorescence intensity was normalized using the GPI-T unit definition. See text
for details. n = 1 Initial rates of transamidation for assays with (B i) 10 mM NH2OH ,(B
ii) 10 mM NH2NH2 ,(B iii) 10 mM EPME and (B iv) no nucleophile (C) Structure of
EPME. Refer to table A1 for experimental conditions.

114
Table A1 Experimental conditions for assays described in appendix A

Changes to standard Assay/Assay buffer
Figure

Additives
conditions *

A1.C

no 10 mM NH2OH

A1.D

No GPI-T

A2.C

24 mM Igepal

-

A2.D

24 mM Igepal

no Digitonin

A3.B

-

0.05% Digitonin

A3.D

-

0.2% Digitonin

A3.E

-

0.3% Digitonin

A5.C

no 1 mM DTT

A6.B

-

1 µL GPI-T

A6.C

-

5 µL GPI-T

A6.E

-

50 µL GPI-T

A7.B

-

5 µM peptide 2

A7.D

-

20 µM peptide 2

A8.B ii

-10 mM NH2NH2

no 10 mM NH2OH

B8.B iii

10 mM EPME

no 10 mM NH2OH

A8.B iv

no 10 mM NH2OH

All experiments were performed with 10 µM peptide 2. Experimental details for the
assays performed under standard conditions (10 mM NH2OH, 50 µL GPI-T, 10 µM peptide 2
with GPI-T assay buffer as detailed section 2.4.2 and 2.4.7) were not included in Table A.1.
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APPENDIX B

Figure B1. Effect of the identity of the ω site amino acid on peptide substrate
recognition by GPI-T. (A) Summary of effects from variations at the ω site on GPIT activity based on fluorescence response. For all assays, fluorescence intensity
was normalized using the GPI-T unit definition. See text for details. Magenta:
peptide 2 (ω = Ser); Brown: peptide 4 (ω = Asp); Purple: peptide 5 (ω = Arg). Error
bars indicate the standard deviation (n=3). (B) Initial rates of transamidation for
peptide 2 with ω = serine. (C) Initial rates of transamidation for peptide 4 with ω =
aspartate. (D) Initial rates of transamidation for peptide 5 with ω = arginine. Refer to
table B1 for experimental conditions.
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Continued on next page
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Figure B2. Effect of the length of the C-terminal GPI-T signal sequence on GPI-T
activity. (A) Summary of effects from variations of the length of the GPI-T signal
sequence on GPI-T activity based on fluorescence response. For all assays,
fluorescence intensity was normalized using the GPI-T unit definition. See text for
details. Magenta: peptide 2 (37 mer); Purple: peptide 6 (33 mer); Maroon: peptide 7
(29 mer); Orange: peptide 8 (25 mer); Black: peptide 9 (23 mer); Cyan: peptide 10 (18
mer). Error bars indicate the standard deviation (n=3). (B) Initial rates of
transamidation for peptide 2. (C) Initial rates of transamidation for peptide 6. (D) Initial
rates of transamidation for peptide 7. (E) Initial rates of transamidation for peptide 8.
(F) Initial rates of transamidation for peptide 9. (G) Initial rates of transamidation for
peptide 10. For each plot (B-G), the peptide sequence is represented at the top of
plot with the hydrophobic portion highlighted in blue. Refer to table B1 for
experimental conditions.
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Continued on next page
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Figure B3. Species specific substrate selectivity. (A) Summary of effects from
peptides 2 (CD52) and 11 (Yapsin 2) on GPI-T activity, based on fluorescence
responses. For all assays, fluorescence intensity was normalized using the GPI-T unit
definition. See text for details. Magenta: 10 µM peptide 2 (CD52); Orange: 10 µM
peptide 11 (Yapsin 2); Purple: 20 µM peptide 11 (Yapsin 2); Maroon: 50 µM peptide
11 (Yapsin 2); n=2. (B) Initial rates of transamidation for 10 µM peptide 2. (C) Initial
rates of transamidation for 10 µM peptide 11. (D) Initial rates of transamidation for 20
µM peptide 11. (E) Initial rates of transamidation for 50 µM peptide 11. (F) Species
specificity of GPI-T in terms of relative rates. Relative rates were calculated with
respect to the assay with 10 µM peptide 2 (■). For each plot (B-E), the peptide
sequences is represented at the top of plot. Refer to table B1 for experimental
conditions.
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Continued on next page
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Figure B4. Effect of transition metals on GPI-T activity. (A) Summary of effects
from different transition metals on GPI-T activity, based on fluorescence response.
For all assays, fluorescence intensity was normalized using the GPI-T unit definition.
See text for details. Magenta: 1 mM Mn2+; Purple: 1 mM Zn2+; Orange: 1 mM Mn2+ & 1
mM Zn2+; Gray: 1 mM Cu2+; Cyan: 1 mM Fe2+; Maroon: 1 mM EDTA. Error bars
indicate the standard deviation (n=3). (B) Initial rates of transamidation for assay with
1 mM Mn2+. (C) Initial rates of transamidation for assay with 1 mM Zn2+. (D) Initial
rates of transamidation for assay with 1 mM Mn2+ + 1 mM Zn2+. (E) Initial rates of
transamidation for assay with 1 mM Cu2+. (F) Initial rates of transamidation for assay
with 1 mM Fe2+. (G) Initial rates of transamidation for assay with 1 mM EDTA. Refer
to table B1 for experimental conditions.
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Figure B5 Effect of Leupeptin on catalytic activity of GPI-T. (A) Summary of
effects from leupeptin and PMSF on GPI-T activity based on fluorescence response.
For all assays, fluorescence intensity was normalized using the GPI-T unit definition.
See text for details. Magenta: 1 mM PMSF; Purple: 1 mM Leupeptin + 1 mM PMSF.
Error bars indicate the standard deviation (n=3). (B) Initial rates of transamidation for
assay with 1 mM PMSF. (C) Initial rates of transamidation for assay with 1 mM PMSF
+ Leupeptin. Refer to table B1 for experimental conditions.
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Figure B6. Effect of nucleotides on the catalytic activity of GPI-T. (A) Summary
of effects from different nucleotides on GPI-T based on fluorescence response. For
all assays, fluorescence intensity was normalized using the GPI-T unit definition. See
text for details. Magenta: no NTP; Purple: 10 mM ATP; Maroon: 10 mM GTP. Error
bars indicate the standard deviation (n=3). (A) Initial rates of transamidation for assay
with no NTP. (B) Initial rates of transamidation for assay with 10 mM ATP. (C) Initial
rates of transamidation for assay with 10 mM GTP. Refer to table B1 for experimental
conditions.
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Table B1. Experimental conditions for assays in appendix B
Peptide
Figure

Peptide

Additive
concentration

B1.B

2

10 µM

-

B1.C

4

10 µM

-

B1,D

5

10 µM

-

B2.B

2

10 µM

-

B2.C

6

10 µM

-

B2.D

7

10 µM

-

B2.E

8

10 µM

-

B2.F

9

10 µM

-

B2.G

10

10 µM

-

B3.B

2

10 µM

-

B3.C

11

10 µM

-

B3.D

11

20 µM

-

B3.E

11

50 µM

-

B4.B

2

10 µM

1 mM Mn2+

B4.C

2

10 µM

1 mM Zn2+

B4.D

2

10 µM

1 mM Mn2+ + Zn2+

B4.E

2

10 µM

1 mM Cu2+

B4.F

2

10 µM

1 mM Fe2+

B4.G

2

10 µM

1 mM EDTA
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B5.B

2

10 µM

1 mM PMSF

B5.C

2

10 µM

1 mM PMSF +
1 mM Leupeptin

B6.A

2

10 µM

-

B6.B

2

10 µM

1 mM ATP

B6.C

2

10 µM

1 mM GTP

All experiments were performed with 10 mM NH2OH and 50 µL GPI-T in GPI-T assay buffer
(total volume 2 mL) unless otherwise noted in the last column.
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ABSTRACT
DEVELOPMENT AND OPTIMIZATION OF THE FIRST HIGH THROUGHPUT IN
VITRO FRET ASSAY TO CHARACTERIZE THE SACCHAROMYCES
CEREVISIAE GPI TRANSAMIDASE
by
SANDAMALI AMARASINGHA EKANAYAKA
December 2013
Advisor: Dr. Tamara L. Hendrickson
Major: Biochemistry
Degree: Doctor of Philosophy
The enzyme glycosylphosphatidylinositol transamidase (GPI-T) mediates the
attachment of a glycosylphosphatidylinositol (GPI) anchor to the C-terminus of
specific proteins to produce GPI anchored proteins. This post-translational
modification is essential for viability of eukaryotic organisms. However, very little is
known about GPI-T and its catalytic activity. Thus, the research described in this
abstract was conducted to develop an in vitro assay to monitor GPI-T. A highthroughput assay for GPI-T will facilitate innumerable new experiments to study this
complicated enzyme. The three core subunits of GPI-T (Gpi8, Gpi16, and Gaa1)
were co-purified from a GPI8 knockout Saccharomyces cerevisiae strain containing
a plasmid that expresses Gpi8 with an appended glutathione-S-transferase (GST)
domain. Peptide substrates for GPI-T were synthesized and modified to contain a
pair of chromophores suitable for the development of a fluorescence resonance
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energy transfer (FRET) assay. GPI-T activity was observed as a time-dependent
increase in fluorescence by incubating peptides with pure, solubilized GPI-T in the
presence of hydroxylamine, a small GPI anchor mimic. A FRET assay was
developed and optimized to monitor GPI anchoring activity in vitro. The assay was
used to investigate various aspects of GPI-T, including the importance of the Cterminal hydrophobic region in peptide substrates, the identity of the residue at the
site of modification, substrate selectivity, and the effect of cofactors, co-substrates
and inhibitors for GPI-T .To date no one has demonstrated robust GPI-T activity with
pure solubilized GPI-T. Thus, this new FRET assay represents the first highthroughput method to quantitatively analyze GPI-T activity in vitro.
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